<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29713264</article-id>
<article-id pub-id-type="pmc">5911982</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00124</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling Fragile X Syndrome in <italic>Drosophila</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Drozd</surname>
<given-names>Małgorzata</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bardoni</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/95523/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capovilla</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/416454/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Université Côte d'Azur, CNRS, IPMC</institution>, <addr-line>Valbonne</addr-line>, <country>France</country></aff>
<aff id="aff2"><sup>2</sup><institution>CNRS LIA (Neogenex)</institution>, <addr-line>Valbonne</addr-line>, <country>France</country></aff>
<aff id="aff3"><sup>3</sup><institution>Université Côte d'Azur, INSERM, CNRS, IPMC</institution>, <addr-line>Valbonne</addr-line>, <country>France</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Regina Dahlhaus, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Alicia Mansilla, Instituto Ramón y Cajal de Investigación Sanitaria, Spain; Bassem Hassan, UMR7225 Institut du Cerveau et de la Moelle Épinière (ICM), France</p>
</fn>
<corresp id="c001">*Correspondence: Barbara Bardoni <email>bardoni@ipmc.cnrs.fr</email></corresp>
<corresp id="c002">Maria Capovilla <email>maria.capovilla@ipmc.cnrs.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>124</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Drozd, Bardoni and Capovilla.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Drozd, Bardoni and Capovilla</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Intellectual disability (ID) and autism are hallmarks of Fragile X Syndrome (FXS), a hereditary neurodevelopmental disorder. The gene responsible for FXS is Fragile X Mental Retardation gene 1 (<italic>FMR1</italic>) encoding the Fragile X Mental Retardation Protein (FMRP), an RNA-binding protein involved in RNA metabolism and modulating the expression level of many targets. Most cases of FXS are caused by silencing of <italic>FMR1</italic> due to CGG expansions in the 5′-UTR of the gene. Humans also carry the FXR1 and FXR2 paralogs of FMR1 while flies have only one <italic>FMR1</italic> gene, here called <italic>dFMR1</italic>, sharing the same level of sequence homology with all three human genes, but functionally most similar to <italic>FMR1</italic>. This enables a much easier approach for <italic>FMR1</italic> genetic studies. <italic>Drosophila</italic> has been widely used to investigate <italic>FMR1</italic> functions at genetic, cellular, and molecular levels since <italic>dFMR1</italic> mutants have many phenotypes in common with the wide spectrum of <italic>FMR1</italic> functions that underlay the disease. In this review, we present very recent <italic>Drosophila</italic> studies investigating FMRP functions at genetic, cellular, molecular, and electrophysiological levels in addition to research on pharmacological treatments in the fly model. These studies have the potential to aid the discovery of pharmacological therapies for FXS.</p>
</abstract>
<kwd-group>
<kwd>Fragile X Syndrome</kwd>
<kwd>FMR1</kwd>
<kwd>Fragile X Mental Retardation Protein</kwd>
<kwd>Drosophila</kwd>
<kwd>dFRM1</kwd>
<kwd>neuromuscular junction</kwd>
<kwd>mushroom bodies</kwd>
<kwd>behavior</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="196"></ref-count>
<page-count count="15"></page-count>
<word-count count="14821"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The Fragile X Syndrome (FXS), previously known as Martin-Bell syndrome or marker X syndrome or FRAXA, is the first X-linked intellectual disability (ID) syndrome described involving a DNA alteration and the most frequent heritable monogenic form of ID (reviewed in Penagarikano et al., <xref ref-type="bibr" rid="B144">2007</xref>; Santoro et al., <xref ref-type="bibr" rid="B155">2012</xref>; Hayward et al., <xref ref-type="bibr" rid="B86">2017</xref>). Human FXS patients present severe ID often accompanied by an increase in Autism Spectrum Disorder (ASD) traits and other phenotypes like delayed development, hyperactivity, attention deficit, hypersensitivity to sensorial stimuli, anxiety, aggression, sleep, cardiac disorders, and epileptic seizures (reviewed in Hagerman, <xref ref-type="bibr" rid="B81">2002</xref>; Garber et al., <xref ref-type="bibr" rid="B74">2008</xref>; Utari et al., <xref ref-type="bibr" rid="B177">2010</xref>; Santoro et al., <xref ref-type="bibr" rid="B155">2012</xref>; Hagerman et al., <xref ref-type="bibr" rid="B82">2014</xref>; Kidd et al., <xref ref-type="bibr" rid="B105">2014</xref>; Maurin et al., <xref ref-type="bibr" rid="B121">2014</xref>; Schaefer et al., <xref ref-type="bibr" rid="B156">2015</xref>; Dahlhaus, <xref ref-type="bibr" rid="B45">2018</xref>). These abnormalities can be explained by defects in neuronal development and maturation. Some patients also present characteristic morphological facial traits, macrocephaly, flat feet, and male macroorchidism. The first morphological phenotype observed in FXS patients was the presence of abnormalities in the spines (Comery et al., <xref ref-type="bibr" rid="B38">1997</xref>; Irwin et al., <xref ref-type="bibr" rid="B93">2001</xref>). More recently, ElectroEncephaloGraphy (EEG) and Magnetic Resonance Imaging (MRI) have evidenced volume and Event Related Potential (ERP) defects in FXS patients (Devitt et al., <xref ref-type="bibr" rid="B51">2015</xref>).</p>
<p>FXS was initially associated with an X-chromosome fragile site (an isochromatid gap in metaphase chromosomes) in position Xq27.3 (Harrison et al., <xref ref-type="bibr" rid="B85">1983</xref>). In 1991, this site was mapped to a CGG trinucleotide expansion in the 5′ non-coding region of a gene named <italic>Fragile X Mental Retardation 1</italic> (<italic>FMR1</italic>), the first gene associated with an X-linked ID (Verkerk et al., <xref ref-type="bibr" rid="B181">1991</xref>). <italic>FMR1</italic> is 38 kb long and transcribed in a 4.4 kb full length mRNA that encodes a 632 aa protein called Fragile X Mental Retardation Protein (FMRP). Through alternative splicing, at least 12 different isoforms of 67–80 kD are produced. The CGG repeats are polymorphic in the population ranging from 5 to 54 repeats in normal individuals to more than 200 (full mutation) in severely affected patients (reviewed in Hayward et al., <xref ref-type="bibr" rid="B86">2017</xref>). The repeat expansion results in hypermethylation of the CGG repeat, of a 5′ CpG island, and of flanking promoter sequences causing the reduction or absence of <italic>FMR1</italic> expression through an epigenetic mechanism involving <italic>FMR1</italic> mRNA (Colak et al., <xref ref-type="bibr" rid="B37">2014</xref>). Several deletions and point mutations leading to the production of non-functional proteins have also been described (Okray et al., <xref ref-type="bibr" rid="B140">2015</xref> and references therein). Individuals with 55–200 CGG repetitions (premutation) do not present FXS symptoms, but may develop two other disorders: Fragile-X Primary Ovarian Insufficiency (FXPOI) (reviewed in Sherman et al., <xref ref-type="bibr" rid="B160">2014</xref>) or Fragile X Associated Tremor/Ataxia Syndrome (FXTAS) (reviewed in Hall et al., <xref ref-type="bibr" rid="B83">2016</xref>; Dahlhaus, <xref ref-type="bibr" rid="B45">2018</xref>). FXTAS has been modeled in <italic>Drosophila</italic> by overexpressing 90 rCGG repeats alone fused to GFP, which causes a neuron-specific degeneration and the formation of inclusions (Jin et al., <xref ref-type="bibr" rid="B95">2003</xref>; Qurashi et al., <xref ref-type="bibr" rid="B150">2012</xref>).</p>
<p>In mammals, FMRP is nearly ubiquitous, present mainly in neurons (particularly in the cortex, hippocampus, and Purkinje cells) and in testes and absent from muscles and the heart (Devys et al., <xref ref-type="bibr" rid="B52">1993</xref>). FMRP has two paralogs: Fragile X Related 1 (<italic>FXR1</italic>) and Fragile X Related 2 (<italic>FXR2</italic>). While FXR2 has a distribution comparable to that of FMRP, some isoforms of <italic>FXR1</italic> display a specific expression in brain while other isoforms are only present in muscle and heart (Khandjian et al., <xref ref-type="bibr" rid="B103">1998</xref>; Bechara et al., <xref ref-type="bibr" rid="B15">2007</xref>). These three proteins are members of the same family, namely the Related Fragile X Protein family, and are RNA-binding proteins mainly localized in the cytoplasm, although they carry a Nuclear Localization Signal (NLS) and a Nuclear Exportation Signal (NES) (Bardoni et al., <xref ref-type="bibr" rid="B12">2000</xref>). Indeed, some isoforms of FMRP have also been localized in the nucleus (Eberhart et al., <xref ref-type="bibr" rid="B64">1996</xref>; Bardoni et al., <xref ref-type="bibr" rid="B13">1997</xref>). Collectively, these results have suggested that the three FXR proteins are able to shuttle between nucleus and cytoplasm to export their target mRNAs.</p>
<p>Three RNA-binding sequence motifs are the hallmarks of FMRP that may explain its function, <italic>i.e</italic>., two K homology (KH) domains and one Arginine-Glycine-Glycine (RGG) box. The main function of FMRP is to regulate translation and indeed it has been found associated with polyribosomes in different cell lines and, importantly, in the brain (Khandjian et al., <xref ref-type="bibr" rid="B104">2004</xref>). Although FMRP mainly acts as a repressor, an activator function has been observed (reviewed in Maurin et al., <xref ref-type="bibr" rid="B121">2014</xref>). Many methods have been used to identify FMRP targets (reviewed in Maurin et al., <xref ref-type="bibr" rid="B121">2014</xref>; Davis and Broadie, <xref ref-type="bibr" rid="B48">2017</xref>; Hayward et al., <xref ref-type="bibr" rid="B86">2017</xref>): binding to biotinylated RNAs (Ashley et al., <xref ref-type="bibr" rid="B9">1993</xref>), Cross-Link Immuno Precipitation (CLIP) (Darnell et al., <xref ref-type="bibr" rid="B47">2011</xref>; Ascano et al., <xref ref-type="bibr" rid="B8">2012</xref>; Anderson et al., <xref ref-type="bibr" rid="B6">2016</xref>), Systematic Evolution of Ligands by Exponential Enrichment (SELEX) (Chen et al., <xref ref-type="bibr" rid="B32">2003</xref>), yeast two-hybrid system (Ma et al., <xref ref-type="bibr" rid="B117">2016</xref>), yeast three-hybrid system (Dolzhanskaya et al., <xref ref-type="bibr" rid="B61">2003</xref>), and Antibody-Positioned RNA Amplification (APRA) (Miyashiro et al., <xref ref-type="bibr" rid="B130">2003</xref>). Many of the identified targets have been involved in autism, other neuronal pathologies or gonadal development and many of them encode synaptic proteins (reviewed in Maurin et al., <xref ref-type="bibr" rid="B121">2014</xref>). Finally, FMRP has been linked to the microRNA (miRNA) and Piwi-interacting RNA (piRNA) pathways in Mammals, <italic>Drosophila</italic>, and zebrafish (reviewed in Kelley et al., <xref ref-type="bibr" rid="B101">2012</xref>; Specchia et al., <xref ref-type="bibr" rid="B163">2017</xref>).</p>
</sec>
<sec id="s2">
<title>Functional insights on FXS from <italic>Drosophila</italic> studies</title>
<p>The first model of FXS was the mammalian mouse model (The Dutch-Belgian Fragile X Consortium, <xref ref-type="bibr" rid="B171">1994</xref>; Mientjes et al., <xref ref-type="bibr" rid="B128">2006</xref>), which recapitulates some major patients' phenotypes (Dahlhaus, <xref ref-type="bibr" rid="B45">2018</xref> and references therein). However, ever since then, also research on <italic>Drosophila melanogaster</italic> has brought important knowledge on the basic mechanisms underlying FMRP function. The <italic>Drosophila</italic> homolog of <italic>FMR1</italic> was first identified in 2000 (Wan et al., <xref ref-type="bibr" rid="B183">2000</xref>) and named <italic>dfmr1</italic>. Over the years, it has been called by many different names that are listed in the <italic>Drosophila</italic> database FlyBase (<ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBrf0174476.html">http://flybase.org/reports/FBrf0174476.html</ext-link>). It is now named <italic>Fmr1</italic> with a capital F, meaning that it has been identified through the human homolog <italic>FMR1</italic>. Here, we will call it <italic>dFMR1</italic> to distinguish it from the mouse gene (<italic>Fmr1</italic>). FlyBase names the protein Fmr1, but here we will call it dFMRP with the “d” indicating <italic>Drosophila</italic>. The <italic>dFMR1</italic> gene exhibits high sequence homology with all three human genes (FMRP, FXR1, and FXR2; Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>), but is most functionally related to <italic>FMR1</italic> (Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>; see below). <italic>dFMR1</italic> is 8.7 kb long and transcribed in many different mRNAs of 2–4 kb encoding many different proteins of different sizes (<ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0028734.html">http://flybase.org/reports/FBgn0028734.html</ext-link>). All functional domains are highly conserved with the two KH domains being 75% identical and 85% similar between <italic>dFMR1</italic> and <italic>hFMR1</italic> (Wan et al., <xref ref-type="bibr" rid="B183">2000</xref>).</p>
<p>The gene expression of <italic>dFMR1</italic> in embryos was explored soon after its cloning and observed in the Central Nervous System (CNS), in the somatic musculature, in pole cells, in the gut and in the gonads (Wan et al., <xref ref-type="bibr" rid="B183">2000</xref>; Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Schenck et al., <xref ref-type="bibr" rid="B159">2002</xref>). In Figure <xref ref-type="fig" rid="F1">1</xref>, we show the expression of <italic>dFMR1</italic> at stage 14 by <italic>in situ</italic> hybridization with a full-length probe using the Tyramide Signal Amplification (TSA) (Tevy et al., <xref ref-type="bibr" rid="B170">2014</xref>). High levels of expression are found in the brain (Figure <xref ref-type="fig" rid="F1">1A</xref>, arrowhead), in the CNS (Figure <xref ref-type="fig" rid="F1">1A</xref>, arrow) and in muscle precursors (Figure <xref ref-type="fig" rid="F1">1B</xref>), confirming the previously described pattern of <italic>dFMR1</italic> expression at this stage through a sensitive method.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><italic>dFMR1</italic> expression in stage 14 <italic>Drosophila</italic> embryos<bold>. (A)</bold> Lateral view of a stage 14 embryo (middle focus) showing expression in the brain (arrowhead) and in the CNS (arrow). The salivary gland (asterisk) is non-specific background<bold>. (B)</bold> Lateral view of the same stage 14 embryo (surface focus) showing expression in several muscle precursors. The <italic>dFMR1</italic> anti-sense probe was synthesized from the full length EST-clone LD09557 (Drosophila Genomics Resource Center, Bloomington, IN, USA) linearized with EcoRI and transcribed with the T7 RNA polymerase using the Riboprobe Combination System kit (Promega, Madison, WI) and the DIG RNA Labeling Mix (Roche, Indianapolis, IN). <italic>In situ</italic> hybridization was performed as in Tevy et al. (<xref ref-type="bibr" rid="B170">2014</xref>) except that SA-HRP and TSA were diluted at 1:250. Images were acquired at the SPIBOC imaging platform of the Institut Sophia Agrobiotech (Sophia Antipolis, France) on an Axioplan II microscope using the ZEN software (Carl Zeiss, Germany).</p>
</caption>
<graphic xlink:href="fnmol-11-00124-g0001"></graphic>
</fig>
<p>In embryos, dFMRP has been localized in the brain, ventral nerve cord, and mesoderm (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Schenck et al., <xref ref-type="bibr" rid="B159">2002</xref>; Dolzhanskaya et al., <xref ref-type="bibr" rid="B61">2003</xref>; Ma et al., <xref ref-type="bibr" rid="B117">2016</xref>), muscle attachment sites and dendritic tips of chordotonal organs, dendrites of the trachea-innervating neurons (Schenck et al., <xref ref-type="bibr" rid="B159">2002</xref>), developing egg chambers (Zarnescu et al., <xref ref-type="bibr" rid="B192">2005</xref>; Pepper et al., <xref ref-type="bibr" rid="B145">2009</xref>), and in punctate cytoplasmic structures in cleavage-stage embryos in association with cytoplasmic RNP bodies (Monzo et al., <xref ref-type="bibr" rid="B132">2006</xref>; Papoulas et al., <xref ref-type="bibr" rid="B143">2010</xref>). In larvae, dFMRP has been detected in the CNS, the PNS, the eye disk, the testis, at low levels in muscles, in the Mushroom Bodies (MBs, the <italic>Drosophila</italic> learning and memory center; Schenck et al., <xref ref-type="bibr" rid="B159">2002</xref>) and in dendritic arborization (DA) neurons (Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>). dFMRP is found exclusively in the cytoplasm of the soma of neurons (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>). Finally, in adults dFMRP has been found in the central brain and eyes (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>), in pupal and adult brain neurons (Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>), in specific cells of the adult brain (Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>), in antennal lobe projection neurons (Sudhakaran et al., <xref ref-type="bibr" rid="B165">2014</xref>), and in the cell bodies of specific neurons of the MBs (Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>). Although the main tissue in which dFMRP is present is the CNS, these studies suggest that this protein also has non-neuronal functions, most of which still have to be dissected. Indeed, <italic>dFMR1</italic> has been involved by FlyBase (<ext-link ext-link-type="uri" xlink:href="http://flybase.org/reports/FBgn0028734.html">http://flybase.org/reports/FBgn0028734.html</ext-link>) in 58 biological processes, which are summarized in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Main phenotypes of loss of function <italic>dFMR1</italic> mutants.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>BEHAVIOR</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adult locomotion/Climbing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Dockendorff et al., <xref ref-type="bibr" rid="B55">2002</xref>; Inoue et al., <xref ref-type="bibr" rid="B92">2002</xref>; Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Martinez et al., <xref ref-type="bibr" rid="B120">2007</xref>; Banerjee et al., <xref ref-type="bibr" rid="B11">2010</xref>; Adewoye et al., <xref ref-type="bibr" rid="B4">2015</xref>; Novak et al., <xref ref-type="bibr" rid="B137">2015</xref>; Monyak et al., <xref ref-type="bibr" rid="B131">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Circadian rhythm</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dockendorff et al., <xref ref-type="bibr" rid="B55">2002</xref>; Inoue et al., <xref ref-type="bibr" rid="B92">2002</xref>; Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Banerjee et al., <xref ref-type="bibr" rid="B10">2007</xref>, <xref ref-type="bibr" rid="B11">2010</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B76">2009</xref>; Siller and Broadie, <xref ref-type="bibr" rid="B161">2011</xref>; Xu et al., <xref ref-type="bibr" rid="B189">2012</xref>; Adewoye et al., <xref ref-type="bibr" rid="B4">2015</xref>; Monyak et al., <xref ref-type="bibr" rid="B131">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Courtship</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dockendorff et al., <xref ref-type="bibr" rid="B55">2002</xref>; McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>; Banerjee et al., <xref ref-type="bibr" rid="B10">2007</xref>, <xref ref-type="bibr" rid="B11">2010</xref>; Chang et al., <xref ref-type="bibr" rid="B31">2008</xref>; Choi et al., <xref ref-type="bibr" rid="B33">2010</xref>; Tauber et al., <xref ref-type="bibr" rid="B167">2011</xref>; Gross et al., <xref ref-type="bibr" rid="B79">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Grooming</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tauber et al., <xref ref-type="bibr" rid="B167">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Larval crawling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B188">2004</xref>; Coyne et al., <xref ref-type="bibr" rid="B41">2015</xref>; Günther et al., <xref ref-type="bibr" rid="B80">2016</xref>; Kashima et al., <xref ref-type="bibr" rid="B99">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Olfactory learning and memory</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Bolduc et al., <xref ref-type="bibr" rid="B19">2008</xref>; Kanellopoulos et al., <xref ref-type="bibr" rid="B98">2012</xref>; Andlauer et al., <xref ref-type="bibr" rid="B7">2014</xref>; Sudhakaran et al., <xref ref-type="bibr" rid="B165">2014</xref>; Choi et al., <xref ref-type="bibr" rid="B34">2015</xref>; Monyak et al., <xref ref-type="bibr" rid="B131">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Social behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bolduc et al., <xref ref-type="bibr" rid="B20">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sleep</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bushey et al., <xref ref-type="bibr" rid="B25">2009</xref>; van Alphen et al., <xref ref-type="bibr" rid="B179">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Touch perception</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cvetkovska et al., <xref ref-type="bibr" rid="B43">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>NEURAL PHYSIOLOGY/STRUCTURE</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bouton area</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B75">2008</xref>; Reeve et al., <xref ref-type="bibr" rid="B152">2008</xref>; Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>; Friedman et al., <xref ref-type="bibr" rid="B72">2013</xref>; Cavolo et al., <xref ref-type="bibr" rid="B30">2016</xref>; Doll et al., <xref ref-type="bibr" rid="B60">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bouton/synapse number</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Zarnescu et al., <xref ref-type="bibr" rid="B192">2005</xref>; Banerjee et al., <xref ref-type="bibr" rid="B10">2007</xref>, <xref ref-type="bibr" rid="B11">2010</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B75">2008</xref>; Xu et al., <xref ref-type="bibr" rid="B190">2008</xref>; Pepper et al., <xref ref-type="bibr" rid="B145">2009</xref>; Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>; Beerman and Jongens, <xref ref-type="bibr" rid="B16">2011</xref>; Bhogal et al., <xref ref-type="bibr" rid="B18">2011</xref>; Siller and Broadie, <xref ref-type="bibr" rid="B161">2011</xref>; Friedman et al., <xref ref-type="bibr" rid="B72">2013</xref>; Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>, <xref ref-type="bibr" rid="B99">2017</xref>; Mansilla et al., <xref ref-type="bibr" rid="B119">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Calcium signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tessier and Broadie, <xref ref-type="bibr" rid="B169">2011</xref>; Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>; Sudhakaran et al., <xref ref-type="bibr" rid="B165">2014</xref>; Doll and Broadie, <xref ref-type="bibr" rid="B59">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">M B β-lobe crossing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Michel et al., <xref ref-type="bibr" rid="B127">2004</xref>; McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>; Banerjee et al., <xref ref-type="bibr" rid="B10">2007</xref>; Bolduc et al., <xref ref-type="bibr" rid="B19">2008</xref>; Chang et al., <xref ref-type="bibr" rid="B31">2008</xref>; Beerman and Jongens, <xref ref-type="bibr" rid="B16">2011</xref>; Gross et al., <xref ref-type="bibr" rid="B79">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neural branching</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>; Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>; Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref>, <xref ref-type="bibr" rid="B152">2008</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B75">2008</xref>; Tessier and Broadie, <xref ref-type="bibr" rid="B168">2008</xref>; Xu et al., <xref ref-type="bibr" rid="B190">2008</xref>; Cziko et al., <xref ref-type="bibr" rid="B44">2009</xref>; Pepper et al., <xref ref-type="bibr" rid="B145">2009</xref>; Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>; Bhogal et al., <xref ref-type="bibr" rid="B18">2011</xref>; Siller and Broadie, <xref ref-type="bibr" rid="B161">2011</xref>; Friedman et al., <xref ref-type="bibr" rid="B72">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B106">2013</xref>; Doll and Broadie, <xref ref-type="bibr" rid="B58">2015</xref>; Myrick et al., <xref ref-type="bibr" rid="B134">2015</xref>; Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurite extension</td>
<td align="left" colspan="1" rowspan="1" valign="top">Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Michel et al., <xref ref-type="bibr" rid="B127">2004</xref>; Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>; Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref>; Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neural fasciculation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schenck et al., <xref ref-type="bibr" rid="B157">2003</xref>; Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotransrrission</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Martinez et al., <xref ref-type="bibr" rid="B120">2007</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B75">2008</xref>; Friedman et al., <xref ref-type="bibr" rid="B72">2013</xref>; Doll et al., <xref ref-type="bibr" rid="B60">2017</xref>; Franco et al., <xref ref-type="bibr" rid="B71">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic growth</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Schenck et al., <xref ref-type="bibr" rid="B157">2003</xref>; Abekhoukh et al., <xref ref-type="bibr" rid="B1">2017</xref>; Doll et al., <xref ref-type="bibr" rid="B60">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Branch/Neurite/NMJ/Synaptic length</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>; Schenck et al., <xref ref-type="bibr" rid="B157">2003</xref>; Reeve et al., <xref ref-type="bibr" rid="B152">2008</xref>; Tessier and Broadie, <xref ref-type="bibr" rid="B168">2008</xref>; Bhogal et al., <xref ref-type="bibr" rid="B18">2011</xref>; Siller and Broadie, <xref ref-type="bibr" rid="B161">2011</xref>; Cvetkovska et al., <xref ref-type="bibr" rid="B43">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B106">2013</xref>; Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>; Bozzetti et al., <xref ref-type="bibr" rid="B21">2015</xref>; Myrick et al., <xref ref-type="bibr" rid="B134">2015</xref>; Sterne et al., <xref ref-type="bibr" rid="B164">2015</xref>; Abekhoukh et al., <xref ref-type="bibr" rid="B1">2017</xref>; Doll et al., <xref ref-type="bibr" rid="B60">2017</xref>; Kennedy and Broadie, <xref ref-type="bibr" rid="B102">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Synapse structure</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>; Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>; Schenck et al., <xref ref-type="bibr" rid="B157">2003</xref>; Michel et al., <xref ref-type="bibr" rid="B127">2004</xref>; Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>; McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>; Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref>, <xref ref-type="bibr" rid="B152">2008</xref>; Zarnescu et al., <xref ref-type="bibr" rid="B192">2005</xref>; Banerjee et al., <xref ref-type="bibr" rid="B10">2007</xref>, <xref ref-type="bibr" rid="B11">2010</xref>; Bolduc et al., <xref ref-type="bibr" rid="B19">2008</xref>; Chang et al., <xref ref-type="bibr" rid="B31">2008</xref>; Gatto and Broadie, <xref ref-type="bibr" rid="B75">2008</xref>, <xref ref-type="bibr" rid="B76">2009</xref>; Tessier and Broadie, <xref ref-type="bibr" rid="B168">2008</xref>; Xu et al., <xref ref-type="bibr" rid="B190">2008</xref>; Cziko et al., <xref ref-type="bibr" rid="B44">2009</xref>; Pepper et al., <xref ref-type="bibr" rid="B145">2009</xref>; Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>; Beerman and Jongens, <xref ref-type="bibr" rid="B16">2011</xref>; Bhogal et al., <xref ref-type="bibr" rid="B18">2011</xref>; Siller and Broadie, <xref ref-type="bibr" rid="B161">2011</xref>; Cvetkovska et al., <xref ref-type="bibr" rid="B43">2013</xref>; Friedman et al., <xref ref-type="bibr" rid="B72">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B106">2013</xref>; Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>; Bozzetti et al., <xref ref-type="bibr" rid="B21">2015</xref>; Doll and Broadie, <xref ref-type="bibr" rid="B58">2015</xref>; Gross et al., <xref ref-type="bibr" rid="B79">2015</xref>; Myrick et al., <xref ref-type="bibr" rid="B134">2015</xref>; Sterne et al., <xref ref-type="bibr" rid="B164">2015</xref>; Cavolo et al., <xref ref-type="bibr" rid="B30">2016</xref>; Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>, <xref ref-type="bibr" rid="B99">2017</xref>; Abekhoukh et al., <xref ref-type="bibr" rid="B1">2017</xref>; Doll et al., <xref ref-type="bibr" rid="B60">2017</xref>; Kennedy and Broadie, <xref ref-type="bibr" rid="B102">2017</xref>; Mansilla et al., <xref ref-type="bibr" rid="B119">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Synapse volume</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mansilla et al., <xref ref-type="bibr" rid="B119">2017</xref></td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>OTHERS</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adult eclosion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dockendorff et al., <xref ref-type="bibr" rid="B55">2002</xref>; Inoue et al., <xref ref-type="bibr" rid="B92">2002</xref>; Morales et al., <xref ref-type="bibr" rid="B133">2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aging</td>
<td align="left" colspan="1" rowspan="1" valign="top">Martinez et al., <xref ref-type="bibr" rid="B120">2007</xref>; Bushey et al., <xref ref-type="bibr" rid="B25">2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Apoptosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gatto and Broadie, <xref ref-type="bibr" rid="B77">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Blastoderm cellularization</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deshpande et al., <xref ref-type="bibr" rid="B50">2006</xref>; Monzo et al., <xref ref-type="bibr" rid="B132">2006</xref>; Papoulas et al., <xref ref-type="bibr" rid="B143">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cell cycle</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deshpande et al., <xref ref-type="bibr" rid="B50">2006</xref>; Monzo et al., <xref ref-type="bibr" rid="B132">2006</xref>; Epstein et al., <xref ref-type="bibr" rid="B66">2009</xref>; Callan et al., <xref ref-type="bibr" rid="B26">2010</xref>, <xref ref-type="bibr" rid="B27">2012</xref>; Papoulas et al., <xref ref-type="bibr" rid="B143">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Germline development</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang et al., <xref ref-type="bibr" rid="B196">2004</xref>, <xref ref-type="bibr" rid="B194">2014</xref>; Costa et al., <xref ref-type="bibr" rid="B40">2005</xref>; Deshpande et al., <xref ref-type="bibr" rid="B50">2006</xref>; Megosh et al., <xref ref-type="bibr" rid="B124">2006</xref>; Epstein et al., <xref ref-type="bibr" rid="B66">2009</xref>; Yang et al., <xref ref-type="bibr" rid="B191">2009</xref>; Bozzetti et al., <xref ref-type="bibr" rid="B21">2015</xref>; Jiang et al., <xref ref-type="bibr" rid="B94">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Heart rate</td>
<td align="left" colspan="1" rowspan="1" valign="top">Novak et al., <xref ref-type="bibr" rid="B137">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oviposition</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kacsoh et al., <xref ref-type="bibr" rid="B96">2015a</xref>,<xref ref-type="bibr" rid="B97">b</xref>; Jiang et al., <xref ref-type="bibr" rid="B94">2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Phagocytosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">O'Connor et al., <xref ref-type="bibr" rid="B139">2017</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>It is interesting to note that the phenotypes of <italic>dFMR1</italic> mutants largely recall the pathological symptoms of FXS patients. For instance, some FXS patients have delayed motor development, which can be compared to uncoordinated behavior of flies measured by flight or climbing assays. Moreover, olfactory learning and courtship conditioning of Drosophila can serve to test learning and memory behaviors that are often impaired in FXS patients. Also the changes in neuron structure observed in FXS patients are mimicked in the fly model (reviewed in van Alphen and van Swinderen, <xref ref-type="bibr" rid="B178">2013</xref>). The first <italic>dFMR1</italic> mutants were generated soon after its cloning (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>) and resulted viable and fertile as in humans. Nevertheless, mutant viability is highly sensitive to the genetic background, such that <italic>dFMR1</italic> mutants can become fully lethal in some backgrounds (see Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>) in a generation-dependent manner, a phenomenon that requires further study. These original alleles were loss-of-function excisions of hypomorphic EP insertions (producing over-expression of the gene in which they are inserted) presenting phenotypes upon over-expression in the eye (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>). Other null mutants were obtained by excision of other EP elements (Dockendorff et al., <xref ref-type="bibr" rid="B55">2002</xref>; Inoue et al., <xref ref-type="bibr" rid="B92">2002</xref>) or by EMS mutagenesis (Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>). Altogether, <italic>dFMR1</italic> mutants show defects in many different biological functions listed in Table <xref ref-type="table" rid="T1">1</xref>. Over-expression studies in flies have also provided evidence for understating the mis-functions of mutant human FMRP as in the case of the assessment of a neomorphic function for a frameshift FMRP mutant (Okray et al., <xref ref-type="bibr" rid="B140">2015</xref>). In summary, <italic>dFMR1</italic> mainly plays a crucial role in synaptic plasticity and this affects many neuronal processes that are important for fly behavior.</p>
<p>RNA-mediated interference (RNAi) enables the knockdown of a gene of interest at the post-transcriptional stage (Fire et al., <xref ref-type="bibr" rid="B69">1998</xref>). Combining the RNAi with the UAS/GAL4 system (Brand and Perrimon, <xref ref-type="bibr" rid="B23">1993</xref>) in flies makes it possible to down-regulate gene expression in certain tissues and/or at a desired stage of development. Using this combined mechanism, the promoter-GAL4 fusion drives the expression of the RNAi hairpin fragment under the control of UAS sequences (Piccin et al., <xref ref-type="bibr" rid="B146">2001</xref>). Tissue- or stage-specific expression is achieved by the use of specific GAL4 drivers. For instance, <italic>elav-GAL4</italic> is usually used to trigger pan-neuronal expression, <italic>mef2-GAL4</italic> for pan-muscular expression and <italic>Act5c-GAL4</italic> for ubiquitous expression. Since 2007, the Vienna Drosophila Resource Center (VDRC; <ext-link ext-link-type="uri" xlink:href="http://stockcenter.vdrc.at/control/main">http://stockcenter.vdrc.at/control/main</ext-link>; Dietzl et al., <xref ref-type="bibr" rid="B54">2007</xref>) has established many RNAi lines of <italic>D. melanogaster</italic>. These comprise around 12,671 (91%) of <italic>Drosophila</italic> protein-coding genes, making it the largest collection of RNAi lines for all model systems. Currently, there are three different types of UAS-RNAi stocks available: GD and KK with long hairpins and shRNA with short hairpin micro RNAs. The existence of such a broad array of RNAi lines provides many experimental benefits for biological studies, including those focusing on FMRP. For example, tissue-specific RNAi studies uncovered the role of dFMRP in early developmental stages of fly larvae. It was shown that dFMRP regulates glial-dependent proper timing of neuroblast reactivation during brain development (Callan et al., <xref ref-type="bibr" rid="B27">2012</xref>). In another study, RNAi knockdown of <italic>Torsin</italic> revealed its involvement in locomotion. <italic>Torsin</italic> probably works together with <italic>dFMR1</italic> to regulate synaptic plasticity and <italic>dFMR1</italic> expression is altered in <italic>Torsin</italic> mutant flies (Nguyen et al., <xref ref-type="bibr" rid="B136">2016</xref>). By creating the cardiac-specific <italic>dFMR1</italic> RNAi knockdown, <italic>dFmr1</italic> was also shown to be involved in regulating heart rate during development using the climbing assay. In this simple assay, adults are placed in a vial and tapped down. The time by which they reach the height of 5 cm is then measured (Novak et al., <xref ref-type="bibr" rid="B137">2015</xref>). Some FMR1 patients present cardiac defects (Kidd et al., <xref ref-type="bibr" rid="B105">2014</xref>) and changes in FMRP levels have been associated with structural and functional defects in zebrafish and mice (Mientjes et al., <xref ref-type="bibr" rid="B129">2004</xref>; Van't Padje et al., <xref ref-type="bibr" rid="B180">2009</xref>). On the contrary, in <italic>Drosophila</italic> no structural defects have been found, suggesting that <italic>dFMR1</italic> and <italic>FMR1</italic> regulate distinct targets. In a different study, hemocyte-specific <italic>dFMR1</italic> knockdown by RNAi causes a defect in immune cell phagocytosis of bacteria and increases <italic>Drosophila</italic> sensitivity to bacterial infections, suggesting that <italic>dFMR1</italic> is involved in the regulation of phagocytosis (O'Connor et al., <xref ref-type="bibr" rid="B139">2017</xref>; reviewed in Logan, <xref ref-type="bibr" rid="B116">2017</xref>). This study can provide further insights into the engagement of the immune system in FXS pathogenesis, especially considering the fact that some FXS patients exhibit defects in this system (O'Connor et al., <xref ref-type="bibr" rid="B139">2017</xref> and references therein). Aberrations in calcium homeostasis are connected with changes in neuron structure that probably cause the learning and memory deficits seen in FXS patients (Tessier and Broadie, <xref ref-type="bibr" rid="B169">2011</xref> and references therein). This was supported by RNAi knockdown of <italic>dFMR1</italic> during a critical period of development, which proved the importance of the dFMRP role in regulating calcium signaling in the learning and memory circuitry (Doll and Broadie, <xref ref-type="bibr" rid="B59">2016</xref>). These studies highlight the value of the <italic>Drosophila</italic> system in detailed phenotypic analyses of FMRP function.</p>
<p>NeuroMuscular Junctions (NMJs) of <italic>Drosophila</italic> are simple synapses that resemble those present in the Vertebrate CNS. Thus, they are a good model for the study of synapses (reviewed in Menon et al., <xref ref-type="bibr" rid="B126">2013</xref>). The neuromuscular system of <italic>Drosophila</italic> contains 32 motor neurons in each abdominal hemisegment. NMJ synapses show developmental and functional plasticity. They are large and individually specified, enabling their visualization. NMJs are composed of branches and three types of boutons (I, II, and III) that are oval structures hosting synapses differing in size, shape, physiology, and in the amount of sub-synaptic reticulum surrounding them. Type I boutons are glutamatergic and have been the focus of FXS studies. Immunohistological staining can be used to visualize these structures and observe different NMJ phenotypes. <italic>dFMR1</italic> is expressed pre-synaptically in motor neurons (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>), but post-synaptically in muscles (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>; Schenck et al., <xref ref-type="bibr" rid="B159">2002</xref>). In <italic>dFMR1</italic> mutants, NMJs display increased synapse arborization and branching, increased synaptic bouton numbers, and elevated neurotransmission, whereas larvae over-expressing <italic>dFMR1</italic> show the opposite phenotypes (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>). These phenotypes recall the dendritic spine over-growth observed in mammalian mutants and in FXS patients (Irwin et al., <xref ref-type="bibr" rid="B93">2001</xref>).</p>
<p>In addition to defects in NMJ synaptic architecture in neurons, <italic>dFMR1</italic> mutants also exhibit fecundity and testes dysfunctions, which can be used to evaluate non-neuronal requirements (Zhang et al., <xref ref-type="bibr" rid="B196">2004</xref>). Coffee et al. examined the evolutionary conservation of <italic>FMR1</italic> and its paralogs in the <italic>Drosophila</italic> FXS model at the neuronal and non-neuronal levels (Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>). In this study, out of the three human genes, only <italic>FMR1</italic> turned out to be able to restore the normal number of boutons in <italic>dFMR1</italic> null mutants. On the other hand, all three homologs rescued the sterility and testicular phenotypes. These results indicate that in neurons <italic>FMR1</italic> has a unique evolutionarily conserved role. In contrast, in non-neuronal tissues <italic>FMR1, hFXR1</italic>, and <italic>hFXR2</italic> are able to substitute each other (Coffee et al., <xref ref-type="bibr" rid="B36">2010</xref>).</p>
<p>The larval NMJ has proved a powerful system to study genetic interactions occurring in the actin remodeling pathway that is altered in mammalian FMRP-null neurons (Castets et al., <xref ref-type="bibr" rid="B29">2005</xref>; Pyronneau et al., <xref ref-type="bibr" rid="B149">2017</xref>). FMRP has been shown to interact with Cytoplasmic FMRP Interacting Protein 1 (CYFIP1) <italic>in vitro</italic> (Schenck et al., <xref ref-type="bibr" rid="B158">2001</xref>, <xref ref-type="bibr" rid="B157">2003</xref>) and also in both mammals (Schenck et al., <xref ref-type="bibr" rid="B158">2001</xref>) and <italic>Drosophila</italic> (Schenck et al., <xref ref-type="bibr" rid="B157">2003</xref>; Abekhoukh et al., <xref ref-type="bibr" rid="B1">2017</xref>). CYFIP1 is part of the WAVE regulatory complex (WRC) along with five other proteins involved in actin polymerization (reviewed in Cory and Ridley, <xref ref-type="bibr" rid="B39">2002</xref>; Takenawa and Suetsugu, <xref ref-type="bibr" rid="B166">2007</xref>). Human CYFIP1 has been linked to neurodevelopmental disorders such as ID, autism, schizophrenia, epilepsy, and Burnside-Butler (15q11.2 BP1-BP2 micro-deletion) syndrome (Madrigal et al., <xref ref-type="bibr" rid="B118">2012</xref>; Waltes et al., <xref ref-type="bibr" rid="B182">2014</xref>; Huang, <xref ref-type="bibr" rid="B88">2015</xref>; Wang et al., <xref ref-type="bibr" rid="B184">2015</xref>). Abekhoukh et al. (<xref ref-type="bibr" rid="B1">2017</xref>) utilized the fine genetic tools of <italic>Drosophila</italic> to investigate the genetic interactions between dFMRP and dCYFIP1. Through loss- and gain-of-functions studies, the authors showed that <italic>dFMR1</italic> and d<italic>CYFIP1</italic> have opposing functions on larval NMJ length: dFMRP represses while dCYFIP1 promotes synaptic growth at the NMJ in gene dosage studies using the presynaptic <italic>elav-Gal4</italic> driver. A rescue of the reciprocal NMJ length phenotypes is observed in double homozygous mutant animals. It should be noted that double homozygous mice are lethal, thus preventing a similar epistatic genetic analysis in the mouse model. Here, the advantage of <italic>Drosophila</italic> for synaptic plasticity and actin studies is that specific parameters can easily be monitored. Since <italic>dFMR1</italic> and <italic>CYFIP1</italic> are candidates for ID and autism, these studies on the fly pave the way to deeper and more refined studies in mice and in humans.</p>
<p>The first <italic>Drosophila</italic> target of dFMRP was the gene <italic>futsch</italic>, identified by RNA immunoprecipitation (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>). This gene encodes a microtubule-associated protein with homology to mammalian MAP1B. <italic>futsch</italic> and <italic>dFMR1</italic> have opposite phenotypes (undergrowth and overgrowth of synaptic boutons, respectively) and dFMRP binds <italic>futsch</italic> mRNA, negatively regulating its translation (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>). Binding of dFMRP was also found for the mRNA of the actin monomer binding protein <italic>profilin</italic> (encoded by <italic>chickadee</italic>; Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref>) and of the small GTPase Rac1 (Lee et al., <xref ref-type="bibr" rid="B111">2003</xref>), whose loss- and gain-of-functions also have opposite phenotypes to those of <italic>dFMRP</italic> that are rescued by over-expression of both genes. dFMRP also binds the mRNAs of BMPR2 (Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>), DSCAM (Cvetkovska et al., <xref ref-type="bibr" rid="B43">2013</xref>), and the Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) mRNA together with Ataxin-2 (Sudhakaran et al., <xref ref-type="bibr" rid="B165">2014</xref>), confirming the involvement of <italic>dFMR1</italic> in the Ca<sup>2+</sup> pathway. Nevertheless, there is still a need for high throughput studies to identify novel dFMRP targets.</p>
<p>MBs consist of bilateral clusters of ~2,500 neurons in the fly brain. In MBs, there are three types of intrinsic neurons: αβ, α′β′, and γ (Crittenden et al., <xref ref-type="bibr" rid="B42">1998</xref>). α′β′ are a prerequisite for gaining olfactory memory, whereas αβ are required to retrieve memory (Krashes et al., <xref ref-type="bibr" rid="B110">2007</xref>). MBs play a major role in olfactory learning and memory in <italic>Drosophila</italic>. Odor and courtship-based tests are frequently used to assess memory dysfunctions in this system (reviewed in Weisz et al., <xref ref-type="bibr" rid="B186">2015</xref>). MBs are also involved in visual context generalization, information processing, locomotion, sleep, courtship conditioning, and choice behavior. The MB axons in <italic>dFMR1</italic> null mutants show architectural defects such as an increase in volume and branching, as well as abnormalities in synapse formation (Pan et al., <xref ref-type="bibr" rid="B141">2004</xref>; Chang et al., <xref ref-type="bibr" rid="B31">2008</xref>). <italic>dFMR1</italic> null mutants show morphological MB defects in the lobes, the most frequent of which is the failure of β-lobe arrest at the brain midline (Michel et al., <xref ref-type="bibr" rid="B127">2004</xref> and see Table <xref ref-type="table" rid="T1">1</xref>), whereas over-expression of <italic>dFMR1</italic> causes the opposite phenotype (Reeve et al., <xref ref-type="bibr" rid="B151">2005</xref>). These MB malformations can be restored through pharmacological treatment, but they are not indispensable for restoring memory (McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>). It has been shown that <italic>dFMR1</italic> expression requirements differ between lobe types in MBs. Simultaneous expression of <italic>dFMR1</italic> in α, β, and γ lobes is essential for learning skills. The lack of <italic>dFMR1</italic> expression in α and β lobes is sufficient to impair associative olfactory learning and memory, whereas the knock-down of <italic>dFMR1</italic> only in γ lobes does not exhibit detrimental effects on learning (Kanellopoulos et al., <xref ref-type="bibr" rid="B98">2012</xref>). The MBs have also been the focus of calcium-signaling studies using a transgenic GCaMP calcium sensor (Doll and Broadie, <xref ref-type="bibr" rid="B59">2016</xref> and references therein). The MB neurons have been shown to be involved in activity-dependent processes during critical period development thanks to their ability to respond when illuminated by a blue light (see below; reviewed in Doll and Broadie, <xref ref-type="bibr" rid="B57">2014</xref>). All the <italic>dFMR1</italic> phenotypes in the MBs correlate with learning and memory dysfunctions and make the FXS <italic>Drosophila</italic> model very appealing because of its easy <italic>in vivo</italic> analysis and the wide range of tools that have been developed (Ugur et al., <xref ref-type="bibr" rid="B176">2016</xref>; Chow and Reiter, <xref ref-type="bibr" rid="B35">2017</xref>).</p>
<p>Electrophysiological techniques have been used in <italic>Drosophila</italic> to study the effect of <italic>dFMR1</italic> loss-of-function and over-expression on synaptic transmission. Two-Electrode Voltage Clamp (TEVC) studies at NMJs in <italic>Drosophila</italic> showed that FMRP has clear pre-synaptic functions (Zhang et al., <xref ref-type="bibr" rid="B195">2001</xref>), although photoreceptor synaptic transmission is normal in the mutants (Morales et al., <xref ref-type="bibr" rid="B133">2002</xref>). Through TEVC recordings, Gatto and Broadie (<xref ref-type="bibr" rid="B75">2008</xref>) showed that presynaptic <italic>dFMR1</italic> expression in <italic>dFMR1</italic> mutants rescues the defects in NMJ structure, but not in neurotransmission, suggesting that dFMRP also has post-synaptic functions. On the other hand, in mice, FMRP was first shown to act post-synaptically (Huber et al., <xref ref-type="bibr" rid="B89">2002</xref>) and only recently has also been found to play a pre-synaptic role in signal transmission (Koga et al., <xref ref-type="bibr" rid="B108">2015</xref>; Myrick et al., <xref ref-type="bibr" rid="B134">2015</xref>; Zhang et al., <xref ref-type="bibr" rid="B193">2015</xref>) as in the fly. The possibility to target gene expression to specific cells through the UAS/GAL4 system (Brand and Perrimon, <xref ref-type="bibr" rid="B23">1993</xref>), the wide availability of genetic mutants and the precise spatial and temporal resolutions make electrophysiology a very informative technique for FXS modeling in flies, and a useful complement to the advanced imaging studies described below.</p>
<p>Optogenetics is an <italic>in vivo</italic> technique that uses light to measure neuronal activity in living tissues and has also been exploited in the FXS <italic>Drosophila</italic> model. For example, dFMRP has been shown to play a cell-specific role in the regulation of activity-dependent calcium transients that is restricted to the early critical period (Tessier and Broadie, <xref ref-type="bibr" rid="B169">2011</xref>; Doll and Broadie, <xref ref-type="bibr" rid="B59">2016</xref>). Using optogenetic stimulation, it was recently established that <italic>dFMR1</italic> mutants show increased circuit excitability (probably due to reduced GABAergic lateral inhibition; Franco et al., <xref ref-type="bibr" rid="B71">2017</xref>) and that dFMRP is required for the activity-dependent regulation of synaptic connectivity (Doll et al., <xref ref-type="bibr" rid="B60">2017</xref>). These data may explain the deficits in olfactory behaviors and the hyper-excitation found in FXS patients. <italic>Drosophila</italic> has been used to study even sleep patterns in <italic>dFMR1</italic> mutants by electrophysiology and optogenetics. <italic>dFMR1</italic> mutants show deeper night-like sleep during the day (van Alphen et al., <xref ref-type="bibr" rid="B179">2013</xref>), which is likely because of the FMRP function in synaptic remodeling. It is clear that, through <italic>Drosophila</italic>, the cellular and physiological processes involved in FXS pathology can be studied at a deeper level than in any other model system. In addition, flies have been used for pharmacological studies on FXS through their complex behaviors like for example olfactory learning and memory, courtship, circadian rhythm, crawling and sleep (see Table <xref ref-type="table" rid="T1">1</xref> and below).</p>
</sec>
<sec id="s3">
<title>FXS in other model systems</title>
<p><italic>Drosophila</italic> is not the only animal model used to study FXS. Here, we report some examples of other animal models that can help in FXS studies. Mammalian mouse and rat models have been predominantly used for FXS studies. Two different mouse (The Dutch-Belgian Fragile X Consortium, <xref ref-type="bibr" rid="B171">1994</xref>; Mientjes et al., <xref ref-type="bibr" rid="B128">2006</xref>) and rat (Hamilton et al., <xref ref-type="bibr" rid="B84">2014</xref>; Tian et al., <xref ref-type="bibr" rid="B172">2017</xref>) KO models have been generated. It should be noted that, in mice, the full CGG expansion does not cause methylation and <italic>Fmr1</italic> silencing (Brouwer et al., <xref ref-type="bibr" rid="B24">2007</xref>) as it does in humans. Thus, all FXS studies in mice have been carried out using the KO animal (The Dutch-Belgian Fragile X Consortium, <xref ref-type="bibr" rid="B171">1994</xref>; Mientjes et al., <xref ref-type="bibr" rid="B128">2006</xref>). In general, the <italic>Fmr1</italic>-KO mouse is considered to be a good model for this disorder since it recapitulates most FXS phenotypes (deficits in learning and memory, hyperactivity, altered volumes of some brain regions, altered morphology of dendritic spines, and increased size of testis) and because it allows genetic experimentation. Also KO mutant rats present behavioral abnormalities related to ASD-like altered patterns of social interaction (Tian et al., <xref ref-type="bibr" rid="B172">2017</xref>) and social play behavior (Hamilton et al., <xref ref-type="bibr" rid="B84">2014</xref>), defects in visual attention (Berzhanskaya et al., <xref ref-type="bibr" rid="B17">2016</xref>), and speech and auditory dysfunctions (Engineer et al., <xref ref-type="bibr" rid="B65">2014</xref>). Rats have provided an excellent model for neuroscience and pharmacology as they have bigger brains than mice, are easier to train, can learn sophisticated behaviors and have an elaborated social repertoire; however, they are more expensive and much less genetically amenable than mice and flies. These recent studies on <italic>Fmr1</italic> KO mice and rats show that both of these models are useful to study the complex phenotypes of FXS patients. Nevertheless, although Vertebrate model organisms provide more precise insights into the human disease pathogenesis, they are much more difficult than flies to maintain, more time-consuming and incur considerable expenses. In addition, performing experiments on Vertebrate models is much more restrictive in the context of animal laws and often triggers ethical issues.</p>
<p>Other animal models have been generated to understand the physiopathology of FXS, such as the zebrafish, a small fresh water fish endogenous to South-East Asia, the frog <italic>Xenopus laevis</italic> and the marine mollusk <italic>Aplysia californica</italic>. Although zebrafish <italic>fmr1</italic> mutants generated by morpholino knock-down showed gross morphological defects in neurons (Tucker et al., <xref ref-type="bibr" rid="B175">2006</xref>), true genetic null alleles later obtained by random mutagenesis resulted viable, fertile, and of normal morphology (den Broeder et al., <xref ref-type="bibr" rid="B49">2009</xref>) likely due to off-targeting effects of the morpholino technology. Importantly, mutant zebrafish exhibit hyperactivity, learning deficits, impaired anxiety, and increased social behaviors like shoaling (Ng et al., <xref ref-type="bibr" rid="B135">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B107">2014</xref>; Wu et al., <xref ref-type="bibr" rid="B187">2017</xref>) maybe because of hyperactivity as in mice (Sorensen et al., <xref ref-type="bibr" rid="B162">2015</xref>). The frog <italic>fmr1</italic> mutant was also obtained by morpholino KO and showed behavioral (Truszkowski et al., <xref ref-type="bibr" rid="B174">2016</xref>) and FMRP level-sensitive neuronal defects (Faulkner et al., <xref ref-type="bibr" rid="B67">2015</xref>). Finally, in <italic>Aplysia</italic>, basic neurobiological studies have evidenced the pre- and post-synaptic control of plasticity regulating long-term memory and a functional interaction with the Na<sup>+</sup>-activated K<sup>+</sup> channel (K<sub>Na</sub>) Slack (reviewed in Abrams, <xref ref-type="bibr" rid="B2">2012</xref>). Overall, these simpler systems have also facilitated further insights into the mechanisms of FXS pathology.</p>
<p>In comparison to vertebrate models, the more complex human behaviors do not always correspond to those of flies and many neurological diseases can only be modeled in certain aspects. This is mainly due to the fact that <italic>Drosophila</italic> and humans differ in anatomy and despite of having many orthologs in common their pathways exhibit many differences. In addition, although drug administration is much simpler in <italic>Drosophila</italic>, the potential toxicity is much tougher to predict in humans because of significant metabolic differences and complexities (Pandey and Nichols, <xref ref-type="bibr" rid="B142">2011</xref>).</p>
</sec>
<sec id="s4">
<title>Successful pharmacological treatments of FXS phenotypes in <italic>Drosophila</italic></title>
<p>Since the <italic>Drosophila dFMR1</italic> phenotypes recapitulate the patients' symptoms, this model has been used to develop pharmacological treatments for the disease. One reason is that drugs can easily be administered in the standard fly food in which larvae feed and grow. This food is composed of cornmeal, agar and yeast and requires boiling. Recently, the Formula 4–24 (Carolina Biological Supply Company) medium has been exploited because it does not require heating and can simply be dissolved in room temperature water so that even heat-sensitive drugs can be tested (Kashima et al., <xref ref-type="bibr" rid="B99">2017</xref>). Simple feeding has been used in the articles reported below, but many other methods to feed embryos, larvae or adults have been developed (reviewed in Pandey and Nichols, <xref ref-type="bibr" rid="B142">2011</xref>). Another reason is that <italic>Drosophila</italic> does not carry vessels, but all of its organs bathe in hemolymph, which circulates thanks to a tubular heart in an open circulatory system. The fly blood/brain barrier is only made of a thin layer of glial cells presenting septate and gap junctions contrary to the Vertebrate one that is composed of glial cells and of endothelial cells forming tight junctions. Thus, the fly blood/brain barrier is simpler and allows for a better pharmacokinetic penetration (Pinsonneault et al., <xref ref-type="bibr" rid="B147">2011</xref>; Limmer et al., <xref ref-type="bibr" rid="B114">2014</xref>). Here, we discuss some examples of drugs successfully tested on flies to cure <italic>dFMR1</italic> phenotypes that affect the different pathways listed below.</p>
<p>Glutamate is the main excitatory neurotransmitter in the CNS. Metabotropic glutamate receptors (mGluRs) at synapses control Long Term Depression (LTD), which mediates synaptic plasticity, thus weakening the synaptic response to stimuli. mGluR-dependent LTD was initially found to be enhanced in <italic>FMR1</italic> mutant mice (Huber et al., <xref ref-type="bibr" rid="B89">2002</xref>) and later in <italic>Drosophila</italic> (McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>). After the establishment of the “mGluR theory” of FXS by Bear et al. (<xref ref-type="bibr" rid="B14">2004</xref>), it was in <italic>Drosophila</italic> that inhibition of mGluR signaling was first shown to alleviate the behavioral fly phenotypes mimicking human FXS symptoms (McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>). In addition, a rescue of the defects in the fibers crossing the β-lobe of the MBs was observed in the treated <italic>dFMR1</italic> mutants. Interestingly, adult therapy is sufficient to restore normal courtship behavior and short-term memory, but not β-lobe crossing, suggesting that other morphological defects are responsible for the memory defects (McBride et al., <xref ref-type="bibr" rid="B123">2005</xref>). Since then, much research has been carried out to pharmacologically correct this defect both in mice (reviewed in Hagerman et al., <xref ref-type="bibr" rid="B82">2014</xref>) and in flies (Choi et al., <xref ref-type="bibr" rid="B33">2010</xref>; Kanellopoulos et al., <xref ref-type="bibr" rid="B98">2012</xref>). <italic>dFMR1</italic> mutants have less vigorous courtship behavior, learn normally, but forget. Treatments of larvae and adults either with the non-competitive mGluR antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP), three competitive mGluR antagonists or LiCl rescue naive courtship behavior, immediate recall memory and short-term memory of <italic>dFMR1</italic> mutants (Choi et al., <xref ref-type="bibr" rid="B33">2010</xref>). Subsequently, Choi et al. (<xref ref-type="bibr" rid="B33">2010</xref>) compared naive courtship, locomotion, olfactory capabilities, learning, and memory between 20 day-old flies and 5 day-old flies. They found that the inhibitors of the Glutamate receptor pathway and Lithium rescue these phenotypes of <italic>dFMR1</italic> mutants to different degrees. The best rescue is obtained when the treatment is applied at both larval and adult stages. Learning is defective only in old flies, without the involvement of cell death. Treatment with four different mGluR inhibitors or LiCl exclusively during development rescues the learning, but not the courtship defects. Despite these successful treatments in pre-clinical trials, all clinical trials carried out so far have failed, although others are currently underway (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov">https://clinicaltrials.gov</ext-link>). One reason could be the timing of the treatment or the need to combine different drugs since many other molecular mechanisms have been evoked as causative aspects of this disease. Importantly, in addition to FXS, many other neurodevelopmental disorders are correlated with defects in mGluR signaling.</p>
<p>As opposed to glutamate, GABA is the main inhibitory neurotransmitter in the brain. It functions through Gamma-AminoButyric Acid (GABA)<sub>A</sub> and GABA<sub>B</sub> receptors (R) that are fast-acting inotropic and metabotropic receptors, respectively. A decrease in GABA<sub>A</sub> R expression and defects in GABAergic signaling were found in the <italic>FMR1</italic> Knock Out (KO) mouse (Idrissi et al., <xref ref-type="bibr" rid="B91">2005</xref>; D'Hulst et al., <xref ref-type="bibr" rid="B53">2006</xref>; Gantois et al., <xref ref-type="bibr" rid="B73">2006</xref>; Sabanov et al., <xref ref-type="bibr" rid="B154">2017</xref>). GABA<sub>B</sub> R has been linked to mGluR signaling and its reduction associated with autism (reviewed in Hagerman et al., <xref ref-type="bibr" rid="B82">2014</xref>). Many clinical treatments targeted to the GABAergic pathway have been attempted or are underway (reviewed in Braat and Kooy, <xref ref-type="bibr" rid="B22">2015</xref>). Altered GABAergic circuitry, like depressed glutamic acid decarboxylase (GAD) levels, was also found in the <italic>Drosophila</italic> FXS model, particularly in neurons expressing <italic>dFMR1</italic> (D'Hulst et al., <xref ref-type="bibr" rid="B53">2006</xref>; Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>). In this system, through a fine mapping method of Mosaic Analysis with a Repressible Cell Marker (MARCM), Gatto et al. (<xref ref-type="bibr" rid="B78">2014</xref>) showed that <italic>dFMR1</italic> is not required for GABAergic neuron survival, but it regulates the architecture of GABergic neurons innervating the MBs. In addition, <italic>dFMR1</italic> GABAergic neurons display elevated calcium signaling (Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>). To further underline the critical role of the GABA pathway in defining the FXR phenotype in the fly, it is worth mentioning that the down regulation of the GABA receptors in projection neurons of the antennal lobe observed in <italic>dFMR1</italic> mutants is sufficient to produce olfactory behavioral defects (Franco et al., <xref ref-type="bibr" rid="B71">2017</xref>).</p>
<p>Thanks to the toxicity of glutamate for the <italic>dFMR1</italic> mutant, Chang et al. (<xref ref-type="bibr" rid="B31">2008</xref>) were able to carry out an unbiased screen for small molecules that can rescue the lethality of glutamate-treated <italic>dFMR1</italic> mutants, using the mGluR5 non-competitive antagonist MPEP as a positive control. The active compounds belong to biochemical pathways not targeting mGluR signaling, namely the GABAergic, the muscarinic, the serotonin, and hormone-related pathways. Notably, GABA and MPEP treatments were also able to rescue the β-lobe crossing in the MBs and the courtship behavior phenotypes. Indeed, a decrease in GABA<sub>A</sub> R expression and defects in GABAergic signaling were found in the <italic>FMR1</italic> KO mouse (Sabanov et al., <xref ref-type="bibr" rid="B154">2017</xref> and references therein) and in the <italic>Drosophila</italic> FXS model, particularly in neurons expressing <italic>dFMR1</italic> (Gatto et al., <xref ref-type="bibr" rid="B78">2014</xref>). This is the first chemical screen for FXS in flies and was made possible by the easily scorable phenotype of lethality, which revealed novel pathways implicated in FXS (Chang et al., <xref ref-type="bibr" rid="B31">2008</xref>). GABA<sub>B</sub> R has been linked to mGluR signaling and its reduction associated with autism (reviewed in Hagerman et al., <xref ref-type="bibr" rid="B82">2014</xref>). Many clinical treatments targeting the GABAergic pathway have been attempted or are underway (reviewed in Braat and Kooy, <xref ref-type="bibr" rid="B22">2015</xref>).</p>
<p>Another pathway that has been shown to be involved in FXS alterations is the Bone Morphogenetic Protein (BMP) signal transduction pathway (Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>), controlling a number of developmental processes including nervous system development (Liu and Niswander, <xref ref-type="bibr" rid="B115">2005</xref>). This pathway has been linked to anxiety and object exploration in mice (McBrayer et al., <xref ref-type="bibr" rid="B122">2015</xref>). It was previously established that the LIM domain kinase 1 (LIMK1) co-localizes with the BMP type II receptor (BMPR2) in the neuronal terminals (Lee-Hoeflich et al., <xref ref-type="bibr" rid="B113">2004</xref>). These two proteins bind to each other leading to activation of the LIMK1 catalytic activity. Once activated by BMPR2, LIMK1 promotes neural growth and dendritogenesis through phosphorylation and inhibition of cofilin (Meng et al., <xref ref-type="bibr" rid="B125">2002</xref>; Lee-Hoeflich et al., <xref ref-type="bibr" rid="B113">2004</xref>). The C-terminal domain (CTD) of BMPR2 plays a role as a repressor of BMPR2 translation and as an activator of LIMK1 function. Kashima et al. (<xref ref-type="bibr" rid="B100">2016</xref>) found that FMRP binds to the CTD of the BMPR2 and inhibits the translation of full-length BMPR2 in humans and mice. These data have been genetically confirmed in the <italic>Drosophila</italic> model. In the NMJs of <italic>dFMR1</italic> mutants, synaptic boutons are over-grown, whereas they are under-grown in mutants for the BMPR2 homolog <italic>wishful thinking</italic> (<italic>wit</italic>) (see also Eaton and Davis, <xref ref-type="bibr" rid="B63">2005</xref>). Double <italic>wit, dFMR1</italic> mutants show a number of boutons as in single <italic>wit</italic> mutants, indicating that <italic>wit</italic> is negatively regulated by <italic>dFMR1</italic>. These results obtained in the fly encouraged the authors to carry out pharmacological studies in mice that revealed the <italic>Fmr1</italic> rescue potential of a LIMK1 inhibitor (Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>). These cellular phenotypes correlate with the crawling behavior of <italic>Drosophila</italic> larvae, which has been used as a simple genetic and pharmacological screening tool for FXS treatment (Kashima et al., <xref ref-type="bibr" rid="B99">2017</xref>). <italic>dFMR1</italic> mutant larvae crawl faster than wild-type larvae: heterozygotes for three different <italic>dFMR1</italic> alleles show increased larval locomotor activity correlated with an increased bouton number at the NMJ of muscle 6/7 in A3. This phenotype is rescued by a loss-of-function allele of <italic>wit</italic> in heterozygosis suggesting that it is due to an up-regulation of the BMPR2 homolog. The oral treatment with a pharmacological inhibitor of LIMK1 (downstream target of BMPR2, see above) restores the number of boutons in <italic>dFMR1</italic> mutants. Using a newly developed larval crawling assay and a sophisticated algorithm (LarvaTrack) for drug screening, the locomotion defects (distance and velocity) of <italic>dFMR1</italic> larvae were used as a readout of the larval bouton number phenotype (Kashima et al., <xref ref-type="bibr" rid="B99">2017</xref>). In this case, LIMK1 inhibitors and puromycin rescue the <italic>dFMR1</italic> locomotion phenotypes in correlation with the bouton number. Hyperactivity and anxiety of <italic>Fmr1-KO</italic> mice are also ameliorated by treatment with a LIMK inhibitor, showing that this specific and simple assay developed in flies has considerable potential in the assessment of new drug therapies. Indeed, all of these results can be applied to the human condition because an increase in BMPR2 is observed in the prefrontal cortexes of FXS patients (Kashima et al., <xref ref-type="bibr" rid="B100">2016</xref>), paving the way to drug trials in humans.</p>
<p>Neuronal Calcium Sensor 1 (NCS-1) and its <italic>Drosophila</italic> homolog <italic>Frequenin</italic> (<italic>Frq</italic>) 2 are Ca<sup>2+</sup>-binding proteins that play a role in the control of the synapse number: loss-of-function mutations increase the synapse number and over-expression decreases it. Human NCS-1 is involved in schizophrenia (Koh et al., <xref ref-type="bibr" rid="B109">2003</xref>; Torres et al., <xref ref-type="bibr" rid="B173">2009</xref>) and autism (Piton et al., <xref ref-type="bibr" rid="B148">2008</xref>). Frq2 physically interacts with the guanine nucleotide-exchange factor <italic>Ric8a</italic> and the structure of their interaction has been resolved (Romero-Pozuelo et al., <xref ref-type="bibr" rid="B153">2014</xref>). The <italic>Ric8a</italic> protein is localized at larval motor neuron terminals and is particularly abundant in boutons. <italic>Ric8a</italic> knockdown causes a reduction in the number of synapses, thus producing a phenotype opposite to that of Freq2 with Frq2 acting as a negative regulator of Ric8a in the control of the synapse number (Romero-Pozuelo et al., <xref ref-type="bibr" rid="B153">2014</xref>). On the other hand, as in humans and mice (Irwin et al., <xref ref-type="bibr" rid="B93">2001</xref>; Hutsler and Zhang, <xref ref-type="bibr" rid="B90">2010</xref>), loss of <italic>dFMR1</italic> causes an increase in the synapse number and neuron volume (see Table <xref ref-type="table" rid="T1">1</xref>). Mansilla et al. (<xref ref-type="bibr" rid="B119">2017</xref>) identified the aminophenothiazine derivative FD44 as a potent inhibitor of the <italic>Drosophila</italic> NCS-1/Ric8a interaction and showed that treatment of <italic>dFMR1</italic> mutant adults and larvae with this drug reduces their synapse number and volume at the glutamatergic NMJ of larval muscle fibers 6/7 of A3. In addition, FD44 restores normal associative learning. This indicates that, in the <italic>dFMR1</italic> mutant, the interaction between NCS-1 and Ric8a is unbalanced, probably because dFMRP controls <italic>Frq2</italic> transcription (Tessier and Broadie, <xref ref-type="bibr" rid="B169">2011</xref>). Consistently, over-expression of both <italic>NCS-</italic>1 and <italic>Ric8a</italic> restores a normal number of synapses (Romero-Pozuelo et al., <xref ref-type="bibr" rid="B153">2014</xref>). FD44 is an interesting drug because it is small and able to cross the blood/brain barrier and because the structure of the interaction with its target proteins has been clearly illustrated (Mansilla et al., <xref ref-type="bibr" rid="B119">2017</xref>).</p>
<p>The Down Syndrome Cell Adhesion Molecule (DSCAM) is a conserved protein the levels of which have been found to be elevated in many brain disorders including FXS. This has been confirmed in the mouse and <italic>Drosophila</italic> models where it has been shown that FMRP binds the Dscam mRNA and down-regulates its translation (Darnell et al., <xref ref-type="bibr" rid="B46">2001</xref>; Cvetkovska et al., <xref ref-type="bibr" rid="B43">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B106">2013</xref>). <italic>Dscam</italic> encodes a transmembrane protein that is a member of the immunoglobulin superfamily of cell adhesion molecules involved in self-avoidance, synaptic target selection, and axon guidance. In pre-synaptic terminals, <italic>Dscam</italic> has been shown to interact with <italic>Abelson tyrosine kinase</italic> (<italic>Abl</italic>), which mediates the exaggerated presynaptic terminal growth followed by <italic>Dscam</italic> over-expression probably because it is activated by DSCAM (Sterne et al., <xref ref-type="bibr" rid="B164">2015</xref>). As multiple FDA-approved Abl inhibitors were available, Sterne et al. (<xref ref-type="bibr" rid="B164">2015</xref>) tested whether ABL inhibition could restore normal presynaptic terminal growth in larvae over-expressing <italic>Dscam</italic> or mutant for <italic>dFMR1</italic>. The nilotinib inhibitor was found to have this property, which suggests that ABL is as a promising therapeutic target for FXS.</p>
<p>Insulin and insulin-like growth factors (IGF) are evolutionarily highly conserved proteins that play an important role in growth and metabolism, but also in neurogenesis through their role in neuronal stem-cell homeostasis (reviewed in Lee et al., <xref ref-type="bibr" rid="B112">2016</xref>; Ali et al., <xref ref-type="bibr" rid="B5">2018</xref>). In <italic>Drosophila</italic>, expression of <italic>dFMR1</italic> specifically in the insulin-producing cells (IPSs) or in the whole nervous system is able to rescue the defective free-running locomotor rhythmicity of <italic>dFMR1</italic> mutants, as well as short-term and long-term memory defects in olfactory learning tests (Monyak et al., <xref ref-type="bibr" rid="B131">2016</xref>). Protein levels of the major insulin-like peptide DILP2 are elevated in the IPCs of <italic>dFMR1</italic> mutants, suggesting a post-transcriptional control, and markers of the insulin pathway are up-regulated. Through fine genetic manipulations aimed at reducing insulin signaling (IS), the authors were also able to obtain a rescue of the circadian rhythmicity of <italic>dFMR1</italic> flies. These data are consistent with the fact that <italic>FMR1</italic> is expressed in the IPSs of the mammalian pancreas and that insulin and IGFs have been involved in many neurological events, including synaptogenesis and progenitor cell growth (reviewed in Fernandez and Torres-Alemán, <xref ref-type="bibr" rid="B68">2012</xref>). Metformin is a drug used to cure type 2 diabetes that acts as a sensitizer of IS signaling by increasing Phosphatase and TENsin homolog protein (PTEN) expression, AMP-activated protein Kinase (AMPK) activation and decreasing Target Of Rapamycin (TOR) signaling. Treatment of <italic>dFMR1</italic> mutants with metformin restores normal short-term courtship memory and normal olfactory long-term memory (Monyak et al., <xref ref-type="bibr" rid="B131">2016</xref>). Using GAL80, the temperature-sensitive repressor of GAL4, Monyak et al. (<xref ref-type="bibr" rid="B131">2016</xref>) also tested the precise stage at which reduction of IS is necessary to rescue the different behavioral phenotypes of <italic>dFMR1</italic> mutants. While lowering IS during adulthood is sufficient to rescue learning and memory in the olfactory-based paradigm, reduction during the pupal stages is indispensable to rescue circadian behavior. This may mean that dFMRP is required at different developmental steps to temporally modulate IS. The weight of KO <italic>Fmr1</italic> mice is significantly increased compared to wild-type (Dölen et al., <xref ref-type="bibr" rid="B56">2007</xref>) and some FXS patients are obese (Nowicki et al., <xref ref-type="bibr" rid="B138">2007</xref>) and show elevated IS through the mTor pathway in blood and brain (Hoeffer et al., <xref ref-type="bibr" rid="B87">2012</xref>), implying that mis-regulation of the insulin pathway is likely to be one cause of the disease and a promising target for therapy (reviewed in Castagnola et al., <xref ref-type="bibr" rid="B28">2017</xref>).</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>Individuals affected by FXS show a broad spectrum of clinical presentations, with a great variability of signs, symptoms and severity levels (Hagerman, <xref ref-type="bibr" rid="B81">2002</xref>). Indeed, due to the high number of FMR1 targets, FXS can be considered as a multifactorial disorder. The possibility to study null <italic>dFMR1</italic> flies and mice brought significant advantages for understanding the functional roles of FMRP. These systems made it possible to decrypt several pathways responsible for phenotypes recalling human symptoms, such as cognitive and learning deficits. In comparison to the other animal models, <italic>Drosophila</italic> is less expensive and easier to maintain, lays many eggs that enable to perform genetic screens, has a shorter lifespan and generation time, a smaller entirely sequenced genome (Adams et al., <xref ref-type="bibr" rid="B3">2000</xref>) and sophisticated genetic tools to study human diseases like the easiness to make transgenics or to carry out <italic>in vivo</italic> functional studies (reviewed in Wangler et al., <xref ref-type="bibr" rid="B185">2015</xref>; Ugur et al., <xref ref-type="bibr" rid="B176">2016</xref>; Chow and Reiter, <xref ref-type="bibr" rid="B35">2017</xref>). The fly genome has many orthologs displaying similar roles to human disease genes (Fortini et al., <xref ref-type="bibr" rid="B70">2000</xref>; Doronkin and Reiter, <xref ref-type="bibr" rid="B62">2008</xref>) that can be potential targets for functional and therapeutic studies. <italic>dFMR1</italic> mutants exhibit defects that resemble those observed in human FXS patients, and flies and humans share many pathways that are altered in the disease and likely responsible for a specific set of phenotypes. Studies on FXS in <italic>Drosophila</italic> have set a paradigm to validate drug targets and gain a deeper insight into their molecular mechanisms for future research on FXS and other neurodevelopmental diseases. This is also because the dissection of the correlation between pathways and genotypes can be more easily realized in the fly than in any other model system.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We are very grateful to the Drosophila Genomics Resource Center for the <italic>dFMR1</italic> cDNA and to FlyBase for always useful informations. We thank Angela Algeri and Sara Castagnola for their comments on the manuscript, Arnaud Fernandez and Thomas Maurin for valuable discussions, Viviana Trezza for sharing her expertise on the rat model, and Olivier Pierre from SPIBOC for imaging. This study was supported by INSERM, CNRS, CNRS LIA NEOGENEX, ANR-11-LABX-0028-01, ANR-12-BSV4-0020, ANR-12-SVSE8-0022, ANR-15-CE16-0015, and FRM DEQ20140329490 to BB; Monaco Against Autism Foundation to BB and MC. MD is recipient of a Signalife- LabEx Program international Ph.D. fellowship. This review is dedicated to Kathy Matthews, co-founder of the Bloomington Drosophila Stock Center and of FlyBase.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abekhoukh</surname><given-names>S.</given-names></name><name><surname>Sahin</surname><given-names>H. B.</given-names></name><name><surname>Grossi</surname><given-names>M.</given-names></name><name><surname>Zongaro</surname><given-names>S.</given-names></name><name><surname>Maurin</surname><given-names>T.</given-names></name><name><surname>Madrigal</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes</article-title>. <source/>Dis. Model. Mech. <volume>10</volume>, <fpage>463</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.025809</pub-id><pub-id pub-id-type="pmid">28183735</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>T. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Studies on Aplysia neurons suggest treatments for chronic human disorders</article-title>. <source/>Curr. Biol.
<volume>22</volume>, <fpage>R705</fpage>–<lpage>R711</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2012.08.011</pub-id><pub-id pub-id-type="pmid">22975001</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M. D.</given-names></name><name><surname>Celniker</surname><given-names>S. E.</given-names></name><name><surname>Holt</surname><given-names>R. A.</given-names></name><name><surname>Evans</surname><given-names>C. A.</given-names></name><name><surname>Gocayne</surname><given-names>J. D.</given-names></name><name><surname>Amanatides</surname><given-names>P. G.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>The genome sequence of <italic>Drosophila melanogaster</italic></article-title>. <source/>Science
<volume>287</volume>, <fpage>2185</fpage>–<lpage>2195</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5461.2185</pub-id><pub-id pub-id-type="pmid">10731132</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adewoye</surname><given-names>A. B.</given-names></name><name><surname>Kyriacou</surname><given-names>C. P.</given-names></name><name><surname>Tauber</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Identification and functional analysis of early gene expression induced by circadian light-resetting in Drosophila</article-title>. <source/>BMC Genomics
<volume>16</volume>:<fpage>570</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-015-1787-7</pub-id><pub-id pub-id-type="pmid">26231660</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>D.</given-names></name><name><surname>Abuelreich</surname><given-names>S.</given-names></name><name><surname>Alkeraishan</surname><given-names>N.</given-names></name><name><surname>Shwish</surname><given-names>N. B.</given-names></name><name><surname>Hamam</surname><given-names>R.</given-names></name><name><surname>Kassem</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Multiple intracellular signaling pathways orchestrate adipocytic differentiation of human bone marrow stromal stem cells</article-title>. <source/>Biosci. Rep.
<volume>38</volume>:<fpage>BSR20171252</fpage>. <pub-id pub-id-type="doi">10.1042/BSR20171252</pub-id><pub-id pub-id-type="pmid">29298881</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>B. R.</given-names></name><name><surname>Chopra</surname><given-names>P.</given-names></name><name><surname>Suhl</surname><given-names>J. A.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification of consensus binding sites clarifies FMRP binding determinants</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>6649</fpage>–<lpage>6659</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw593</pub-id><pub-id pub-id-type="pmid">27378784</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andlauer</surname><given-names>T. F. M.</given-names></name><name><surname>Scholz-Kornehl</surname><given-names>S.</given-names></name><name><surname>Tian</surname><given-names>R.</given-names></name><name><surname>Kirchner</surname><given-names>M.</given-names></name><name><surname>Babikir</surname><given-names>H. A.</given-names></name><name><surname>Depner</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Drep-2 is a novel synaptic protein important for learning and memory</article-title>. <source/>Elife
<volume>3</volume>:<fpage>e03895</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.03895</pub-id><pub-id pub-id-type="pmid">25392983</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascano</surname><given-names>M.</given-names></name><name><surname>Mukherjee</surname><given-names>N.</given-names></name><name><surname>Bandaru</surname><given-names>P.</given-names></name><name><surname>Miller</surname><given-names>J. B.</given-names></name><name><surname>Nusbaum</surname><given-names>J. D.</given-names></name><name><surname>Corcoran</surname><given-names>D. L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>FMRP targets distinct mRNA sequence elements to regulate protein expression</article-title>. <source/>Nature
<volume>492</volume>, <fpage>382</fpage>–<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1038/nature11737</pub-id><pub-id pub-id-type="pmid">23235829</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>C. T.</given-names></name><name><surname>Wilkinson</surname><given-names>K. D.</given-names></name><name><surname>Reines</surname><given-names>D.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>1993</year>). <article-title>FMR1 protein: conserved RNP family domains and selective RNA binding</article-title>. <source/>Science
<volume>262</volume>, <fpage>563</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1126/science.7692601</pub-id><pub-id pub-id-type="pmid">7692601</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Nayar</surname><given-names>S.</given-names></name><name><surname>Hebbar</surname><given-names>S.</given-names></name><name><surname>Fox</surname><given-names>C. F.</given-names></name><name><surname>Jacobs</surname><given-names>M. C.</given-names></name><name><surname>Park</surname><given-names>J. H.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Substitution of critical isoleucines in the KH domains of Drosophila fragile X protein results in partial loss-of-function phenotypes</article-title>. <source/>Genetics
<volume>175</volume>, <fpage>1241</fpage>–<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.106.068908</pub-id><pub-id pub-id-type="pmid">17194772</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Schoenfeld</surname><given-names>B. P.</given-names></name><name><surname>Bell</surname><given-names>A. J.</given-names></name><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>Bradley</surname><given-names>M. P.</given-names></name><name><surname>Hinchey</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>6782</fpage>–<lpage>6792</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6369-09.2010</pub-id><pub-id pub-id-type="pmid">20463240</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Mandel</surname><given-names>J. L.</given-names></name><name><surname>Fisch</surname><given-names>G. S.</given-names></name></person-group> (<year>2000</year>). <article-title>FMR1 gene and fragile X syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>97</volume>, <fpage>153</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(200022)97:2&lt;153::AID-AJMG7&gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">11180223</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Sittler</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Mandel</surname><given-names>J. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Analysis of domains affecting intracellular localization of the FMRP protein</article-title>. <source/>Neurobiol. Dis.
<volume>4</volume>, <fpage>329</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.1997.0142</pub-id><pub-id pub-id-type="pmid">9440121</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bear</surname><given-names>M. F.</given-names></name><name><surname>Huber</surname><given-names>K. M.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2004</year>). <article-title>The mGluR theory of fragile X mental retardation</article-title>. <source/>Trends Neurosci.
<volume>27</volume>, <fpage>370</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id><pub-id pub-id-type="pmid">15219735</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechara</surname><given-names>E.</given-names></name><name><surname>Davidovic</surname><given-names>L.</given-names></name><name><surname>Melko</surname><given-names>M.</given-names></name><name><surname>Bensaid</surname><given-names>M.</given-names></name><name><surname>Tremblay</surname><given-names>S.</given-names></name><name><surname>Grosgeorge</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure</article-title>. <source/>Nucleic Acids Res.
<volume>35</volume>, <fpage>299</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl1021</pub-id><pub-id pub-id-type="pmid">17170008</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beerman</surname><given-names>R. W.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name></person-group> (<year>2011</year>). <article-title>A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms</article-title>. <source/>Neuroscience
<volume>181</volume>, <fpage>48</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.02.029</pub-id><pub-id pub-id-type="pmid">21333716</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berzhanskaya</surname><given-names>J.</given-names></name><name><surname>Phillips</surname><given-names>M. A.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Colonnese</surname><given-names>M. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Sensory hypo-excitability in a rat model of fetal development in fragile X syndrome</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>30769</fpage>. <pub-id pub-id-type="doi">10.1038/srep30769</pub-id><pub-id pub-id-type="pmid">27465362</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhogal</surname><given-names>B.</given-names></name><name><surname>Jepson</surname><given-names>J. E.</given-names></name><name><surname>Savva</surname><given-names>Y. A.</given-names></name><name><surname>Pepper</surname><given-names>A. S.-R.</given-names></name><name><surname>Reenan</surname><given-names>R. A.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>1517</fpage>–<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2950</pub-id><pub-id pub-id-type="pmid">22037499</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolduc</surname><given-names>F. V.</given-names></name><name><surname>Bell</surname><given-names>K.</given-names></name><name><surname>Cox</surname><given-names>H.</given-names></name><name><surname>Broadie</surname><given-names>K. S.</given-names></name><name><surname>Tully</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory</article-title>. <source/>Nat. Neurosci.
<volume>11</volume>, <fpage>1143</fpage>–<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2175</pub-id><pub-id pub-id-type="pmid">18776892</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolduc</surname><given-names>F. V.</given-names></name><name><surname>Valente</surname><given-names>D.</given-names></name><name><surname>Nguyen</surname><given-names>A. T.</given-names></name><name><surname>Mitra</surname><given-names>P. P.</given-names></name><name><surname>Tully</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>An assay for social interaction in Drosophila fragile X mutants</article-title>. <source/>Fly
<volume>4</volume>, <fpage>216</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.4161/fly.4.3.12280</pub-id><pub-id pub-id-type="pmid">20519966</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzetti</surname><given-names>M. P.</given-names></name><name><surname>Specchia</surname><given-names>V.</given-names></name><name><surname>Cattenoz</surname><given-names>P. B.</given-names></name><name><surname>Laneve</surname><given-names>P.</given-names></name><name><surname>Geusa</surname><given-names>A.</given-names></name><name><surname>Sahin</surname><given-names>H. B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The Drosophila fragile X mental retardation protein participates in the piRNA pathway</article-title>. <source/>J. Cell Sci.
<volume>128</volume>, <fpage>2070</fpage>–<lpage>2084</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.161810</pub-id><pub-id pub-id-type="pmid">25908854</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braat</surname><given-names>S.</given-names></name><name><surname>Kooy</surname><given-names>R. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials</article-title>. <source/>Neuropharmacology
<volume>88</volume>, <fpage>48</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.06.028</pub-id><pub-id pub-id-type="pmid">25016041</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>A. H.</given-names></name><name><surname>Perrimon</surname><given-names>N.</given-names></name></person-group> (<year>1993</year>). <article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title>. <source/>Development
<volume>118</volume>, <fpage>401</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="pmid">8223268</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>J. R.</given-names></name><name><surname>Mientjes</surname><given-names>E. J.</given-names></name><name><surname>Bakker</surname><given-names>C. E.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>I. M.</given-names></name><name><surname>Severijnen</surname><given-names>L. A.</given-names></name><name><surname>Van der Linde</surname><given-names>H. C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation</article-title>. <source/>Exp. Cell Res.
<volume>313</volume>, <fpage>244</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2006.10.002</pub-id><pub-id pub-id-type="pmid">17150213</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bushey</surname><given-names>D.</given-names></name><name><surname>Tononi</surname><given-names>G.</given-names></name><name><surname>Cirelli</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>The Drosophila fragile X mental retardation gene regulates sleep need</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>1948</fpage>–<lpage>1961</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4830-08.2009</pub-id><pub-id pub-id-type="pmid">19228950</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callan</surname><given-names>M. A.</given-names></name><name><surname>Cabernard</surname><given-names>C.</given-names></name><name><surname>Heck</surname><given-names>J.</given-names></name><name><surname>Luois</surname><given-names>S.</given-names></name><name><surname>Doe</surname><given-names>C. Q.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Fragile X protein controls neural stem cell proliferation in the Drosophila brain</article-title>. <source/>Hum. Mol. Genet.
<volume>19</volume>, <fpage>3068</fpage>–<lpage>3079</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq213</pub-id><pub-id pub-id-type="pmid">20504994</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callan</surname><given-names>M. A.</given-names></name><name><surname>Clements</surname><given-names>N.</given-names></name><name><surname>Ahrendt</surname><given-names>N.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Fragile X Protein is required for inhibition of insulin signaling and regulates glial-dependent neuroblast reactivation in the developing brain</article-title>. <source/>Brain Res.
<volume>1462</volume>, <fpage>151</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.03.042</pub-id><pub-id pub-id-type="pmid">22513101</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castagnola</surname><given-names>S.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Maurin</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The search for an effective therapy to treat fragile X syndrome: dream or reality?</article-title>
<source/>Front. Synaptic Neurosci.
<volume>9</volume>:<fpage>15</fpage>
<pub-id pub-id-type="doi">10.3389/fnsyn.2017.00015</pub-id><pub-id pub-id-type="pmid">29163124</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castets</surname><given-names>M.</given-names></name><name><surname>Schaeffer</surname><given-names>C.</given-names></name><name><surname>Bechara</surname><given-names>E.</given-names></name><name><surname>Schenck</surname><given-names>A.</given-names></name><name><surname>Khandjian</surname><given-names>E. W.</given-names></name><name><surname>Luche</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts</article-title>. <source/>Hum. Mol. Genet.
<volume>14</volume>, <fpage>835</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi077</pub-id><pub-id pub-id-type="pmid">15703194</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavolo</surname><given-names>S. L.</given-names></name><name><surname>Bulgari</surname><given-names>D.</given-names></name><name><surname>Deitcher</surname><given-names>D. L.</given-names></name><name><surname>Levitan</surname><given-names>E. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Activity induces Fmr1-sensitive synaptic capture of anterograde circulating neuropeptide vesicles</article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>11781</fpage>–<lpage>11787</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2212-16.2016</pub-id><pub-id pub-id-type="pmid">27852784</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Bray</surname><given-names>S. M.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila</article-title>. <source/>Nat. Chem. Biol.
<volume>4</volume>, <fpage>256</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.78</pub-id><pub-id pub-id-type="pmid">18327252</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Yun</surname><given-names>S. W.</given-names></name><name><surname>Seto</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Toth</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences</article-title>. <source/>Neuroscience
<volume>120</volume>, <fpage>1005</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(03)00406-8</pub-id><pub-id pub-id-type="pmid">12927206</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>McBride</surname><given-names>S. M. J.</given-names></name><name><surname>Schoenfeld</surname><given-names>B. P.</given-names></name><name><surname>Liebelt</surname><given-names>D. A.</given-names></name><name><surname>Ferreiro</surname><given-names>D.</given-names></name><name><surname>Ferrick</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Age-dependent cognitive impairment in a Drosophila fragile X model and its pharmacological rescue</article-title>. <source/>Biogerontology
<volume>11</volume>, <fpage>347</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-009-9259-6</pub-id><pub-id pub-id-type="pmid">20039205</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>Schoenfeld</surname><given-names>B. P.</given-names></name><name><surname>Weisz</surname><given-names>E. D.</given-names></name><name><surname>Bell</surname><given-names>A. J.</given-names></name><name><surname>Chambers</surname><given-names>D. B.</given-names></name><name><surname>Hinchey</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>396</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1356-12.2015</pub-id><pub-id pub-id-type="pmid">25568131</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>C. Y.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Etiology of human genetic disease on the fly</article-title>. <source/>Trends Genetics
<volume>33</volume>, <fpage>391</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2017.03.007</pub-id><pub-id pub-id-type="pmid">28420493</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffee</surname><given-names>R. L.</given-names></name><name><surname>Tessier</surname><given-names>C. R.</given-names></name><name><surname>Woodruff</surname><given-names>E. A.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P</article-title>. <source/>Dis. Model. Mech.
<volume>3</volume>, <fpage>471</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.004598</pub-id><pub-id pub-id-type="pmid">20442204</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colak</surname><given-names>D.</given-names></name><name><surname>Zaninovic</surname><given-names>N.</given-names></name><name><surname>Cohen</surname><given-names>M. S.</given-names></name><name><surname>Rosenwaks</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>W.-Y.</given-names></name><name><surname>Gerhardt</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome</article-title>. <source/>Science
<volume>343</volume>, <fpage>1002</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1126/science.1245831</pub-id><pub-id pub-id-type="pmid">24578575</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comery</surname><given-names>T. A.</given-names></name><name><surname>Harris</surname><given-names>J. B.</given-names></name><name><surname>Willems</surname><given-names>P. J.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><name><surname>Irwin</surname><given-names>S. A.</given-names></name><name><surname>Weiler</surname><given-names>I. J.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits</article-title>. <source/>Proc. Natl. Acad. Sci U.S.A.
<volume>94</volume>, <fpage>5401</fpage>–<lpage>5404</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id><pub-id pub-id-type="pmid">9144249</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cory</surname><given-names>G. O. C.</given-names></name><name><surname>Ridley</surname><given-names>A. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Cell motility: braking WAVEs</article-title>. <source/>Nature
<volume>418</volume>, <fpage>732</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1038/418732a</pub-id><pub-id pub-id-type="pmid">12181548</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Schedl</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>The Drosophila fragile X protein functions as a negative regulator in the orb autoregulatory pathway</article-title>. <source/>Dev. Cell
<volume>8</volume>, <fpage>331</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2005.01.011</pub-id><pub-id pub-id-type="pmid">15737929</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>A. N.</given-names></name><name><surname>Yamada</surname><given-names>S. B.</given-names></name><name><surname>Siddegowda</surname><given-names>B. B.</given-names></name><name><surname>Estes</surname><given-names>P. S.</given-names></name><name><surname>Zaepfel</surname><given-names>B. L.</given-names></name><name><surname>Johannesmeyer</surname><given-names>J. S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>6886</fpage>–<lpage>6898</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv389</pub-id><pub-id pub-id-type="pmid">26385636</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crittenden</surname><given-names>J. R.</given-names></name><name><surname>Skoulakis</surname><given-names>E. M.</given-names></name><name><surname>Han</surname><given-names>K. A.</given-names></name><name><surname>Kalderon</surname><given-names>D.</given-names></name><name><surname>Davis</surname><given-names>R. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Tripartite mushroom body architecture revealed by antigenic markers</article-title>. <source/>Learn. Mem.
<volume>5</volume>, <fpage>38</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="pmid">10454371</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cvetkovska</surname><given-names>V.</given-names></name><name><surname>Hibbert</surname><given-names>A. D.</given-names></name><name><surname>Emran</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>B. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Overexpression of Down syndrome cell adhesion molecule impairs precise synaptic targeting</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>677</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3396</pub-id><pub-id pub-id-type="pmid">23666178</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cziko</surname><given-names>A. M. J.</given-names></name><name><surname>McCann</surname><given-names>C. T.</given-names></name><name><surname>Howlett</surname><given-names>I. C.</given-names></name><name><surname>Barbee</surname><given-names>S. A.</given-names></name><name><surname>Duncan</surname><given-names>R. P.</given-names></name><name><surname>Luedemann</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Genetic modifiers of dFMR1 encode RNA granule components in Drosophila</article-title>. <source/>Genetics
<volume>182</volume>, <fpage>1051</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.109.103234</pub-id><pub-id pub-id-type="pmid">19487564</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Of men and mice: modeling the fragile X syndrome. of men and mice: modeling the fragile X syndrome</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00041</pub-id><pub-id pub-id-type="pmid">29599705</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J. C.</given-names></name><name><surname>Jensen</surname><given-names>K. B.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name><name><surname>Darnell</surname><given-names>R. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function</article-title>. <source/>Cell
<volume>107</volume>, <fpage>489</fpage>–<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00566-9</pub-id><pub-id pub-id-type="pmid">11719189</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J. C.</given-names></name><name><surname>Van Driesche</surname><given-names>S. J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Hung</surname><given-names>K. Y. S.</given-names></name><name><surname>Mele</surname><given-names>A.</given-names></name><name><surname>Fraser</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism</article-title>. <source/>Cell
<volume>146</volume>, <fpage>247</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.06.013</pub-id><pub-id pub-id-type="pmid">21784246</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>J. K.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Multifarious functions of the fragile X mental retardation protein</article-title>. <source/>Trends Genet.
<volume>33</volume>, <fpage>703</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2017.07.008</pub-id><pub-id pub-id-type="pmid">28826631</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Broeder</surname><given-names>M. J.</given-names></name><name><surname>van der Linde</surname><given-names>H.</given-names></name><name><surname>Brouwer</surname><given-names>J. R.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Ketting</surname><given-names>R. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Generation and characterization of FMR1 knockout zebrafish</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e7910</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007910</pub-id><pub-id pub-id-type="pmid">19936290</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>G.</given-names></name><name><surname>Calhoun</surname><given-names>G.</given-names></name><name><surname>Schedl</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>The drosophila fragile X protein dFMR1 is required during early embryogenesis for pole cell formation and rapid nuclear division cycles</article-title>. <source/>Genetics
<volume>174</volume>, <fpage>1287</fpage>–<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.106.062414</pub-id><pub-id pub-id-type="pmid">16888325</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devitt</surname><given-names>N. M.</given-names></name><name><surname>Gallagher</surname><given-names>L.</given-names></name><name><surname>Reilly</surname><given-names>R. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Autism Spectrum Disorder (ASD) and Fragile X syndrome (FXS): two overlapping disorders reviewed through electroencephalography-what can be interpreted from the available information?</article-title>
<source/>Brain Sci.
<volume>5</volume>, <fpage>92</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.3390/brainsci5020092</pub-id><pub-id pub-id-type="pmid">25826237</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devys</surname><given-names>D.</given-names></name><name><surname>Lutz</surname><given-names>Y.</given-names></name><name><surname>Rouyer</surname><given-names>N.</given-names></name><name><surname>Bellocq</surname><given-names>J. P.</given-names></name><name><surname>Mandel</surname><given-names>J. L.</given-names></name></person-group> (<year>1993</year>). <article-title>The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation</article-title>. <source/>Nat. Genet.
<volume>4</volume>, <fpage>335</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1038/ng0893-335</pub-id><pub-id pub-id-type="pmid">8401578</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Hulst</surname><given-names>C.</given-names></name><name><surname>De Geest</surname><given-names>N.</given-names></name><name><surname>Reeve</surname><given-names>S. P.</given-names></name><name><surname>Van Dam</surname><given-names>D.</given-names></name><name><surname>De Deyn</surname><given-names>P. P.</given-names></name><name><surname>Hassan</surname><given-names>B. A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Decreased expression of the GABAA receptor in fragile X syndrome</article-title>. <source/>Brain Res.
<volume>1121</volume>, <fpage>238</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2006.08.115</pub-id><pub-id pub-id-type="pmid">17046729</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietzl</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Schnorrer</surname><given-names>F.</given-names></name><name><surname>Su</surname><given-names>K.-C.</given-names></name><name><surname>Barinova</surname><given-names>Y.</given-names></name><name><surname>Fellner</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila</article-title>. <source/>Nature
<volume>448</volume>, <fpage>151</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/nature05954</pub-id><pub-id pub-id-type="pmid">17625558</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><name><surname>Su</surname><given-names>H. S.</given-names></name><name><surname>McBride</surname><given-names>S. M. J.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>Siwicki</surname><given-names>K. K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest</article-title>. <source/>Neuron
<volume>34</volume>, <fpage>973</fpage>–<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00724-9</pub-id><pub-id pub-id-type="pmid">12086644</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dölen</surname><given-names>G.</given-names></name><name><surname>Osterweil</surname><given-names>E.</given-names></name><name><surname>Rao</surname><given-names>B. S. S.</given-names></name><name><surname>Smith</surname><given-names>G. B.</given-names></name><name><surname>Auerbach</surname><given-names>B. D.</given-names></name><name><surname>Chattarji</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Correction of fragile X syndrome in mice</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>955</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.001</pub-id><pub-id pub-id-type="pmid">18093519</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>C. A.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>30</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00030</pub-id><pub-id pub-id-type="pmid">24570656</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>C. A.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory</article-title>. <source/>Development
<volume>142</volume>, <fpage>1346</fpage>–<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1242/dev.117127</pub-id><pub-id pub-id-type="pmid">25804740</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>C. A.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuron class-specific requirements for fragile X mental retardation protein in critical period development of calcium signaling in learning and memory circuitry</article-title>. <source/>Neurobiol. Dis.
<volume>89</volume>, <fpage>76</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.02.006</pub-id><pub-id pub-id-type="pmid">26851502</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>C. A.</given-names></name><name><surname>Vita</surname><given-names>D. J.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Fragile X mental retardation protein requirements in activity-dependent critical period neural circuit refinement</article-title>. <source/>Curr. Biol.
<volume>27</volume>, <fpage>2318</fpage>–<lpage>2330</lpage>.e3. <pub-id pub-id-type="doi">10.1016/j.cub.2017.06.046</pub-id><pub-id pub-id-type="pmid">28756946</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolzhanskaya</surname><given-names>N.</given-names></name><name><surname>Sung</surname><given-names>Y. J.</given-names></name><name><surname>Conti</surname><given-names>J.</given-names></name><name><surname>Currie</surname><given-names>J. R.</given-names></name><name><surname>Denman</surname><given-names>R. B.</given-names></name></person-group> (<year>2003</year>). <article-title>The fragile X mental retardation protein interacts with U-rich RNAs in a yeast three-hybrid system</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>305</volume>, <fpage>434</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(03)00766-6</pub-id><pub-id pub-id-type="pmid">12745094</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doronkin</surname><given-names>S.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Drosophila orthologues to human disease genes: an update on progress</article-title>. <source/>Prog. Nucleic Acid Res. Mol. Biol.
<volume>82</volume>, <fpage>1</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/S0079-6603(08)00001-9</pub-id><pub-id pub-id-type="pmid">18929137</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>B. A.</given-names></name><name><surname>Davis</surname><given-names>G. W.</given-names></name></person-group> (<year>2005</year>). <article-title>LIM Kinase1 controls synaptic stability downstream of the type II BMP receptor</article-title>. <source/>Neuron
<volume>47</volume>, <fpage>695</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.010</pub-id><pub-id pub-id-type="pmid">16129399</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberhart</surname><given-names>D. E.</given-names></name><name><surname>Malter</surname><given-names>H. E.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>1996</year>). <article-title>The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals</article-title>. <source/>Hum. Mol. Genet.
<volume>5</volume>, <fpage>1083</fpage>–<lpage>1091</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/5.8.1083</pub-id><pub-id pub-id-type="pmid">8842725</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engineer</surname><given-names>C. T.</given-names></name><name><surname>Centanni</surname><given-names>T. M.</given-names></name><name><surname>Im</surname><given-names>K. W.</given-names></name><name><surname>Rahebi</surname><given-names>K. C.</given-names></name><name><surname>Buell</surname><given-names>E. P.</given-names></name><name><surname>Kilgard</surname><given-names>M. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Degraded speech sound processing in a rat model of fragile X syndrome</article-title>. <source/>Brain Res.
<volume>1564</volume>, <fpage>72</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.03.049</pub-id><pub-id pub-id-type="pmid">24713347</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>A. M.</given-names></name><name><surname>Bauer</surname><given-names>C. R.</given-names></name><name><surname>Ho</surname><given-names>A.</given-names></name><name><surname>Bosco</surname><given-names>G.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Drosophila Fragile X protein controls cellular proliferation by regulating cbl levels in the ovary</article-title>. <source/>Dev. Biol.
<volume>330</volume>, <fpage>83</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.03.011</pub-id><pub-id pub-id-type="pmid">19306863</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>R. L.</given-names></name><name><surname>Wishard</surname><given-names>T. J.</given-names></name><name><surname>Thompson</surname><given-names>C. K.</given-names></name><name><surname>Liu</surname><given-names>H.-H.</given-names></name><name><surname>Cline</surname><given-names>H. T.</given-names></name></person-group> (<year>2015</year>). <article-title>FMRP regulates neurogenesis <italic>in vivo</italic> in <italic>Xenopus laevis</italic> tadpoles</article-title>. <source/>eNeuro
<volume>2</volume>:<fpage>e0055</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0055-14.2014</pub-id><pub-id pub-id-type="pmid">25844398</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>A. M.</given-names></name><name><surname>Torres-Alemán</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>The many faces of insulin-like peptide signalling in the brain</article-title>. <source/>Nat. Rev. Neurosci.
<volume>13</volume>, <fpage>225</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3209</pub-id><pub-id pub-id-type="pmid">22430016</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fire</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Montgomery</surname><given-names>M. K.</given-names></name><name><surname>Kostas</surname><given-names>S. A.</given-names></name><name><surname>Driver</surname><given-names>S. E.</given-names></name><name><surname>Mello</surname><given-names>C. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Potent and specific genetic interference by double-stranded RNA in <italic>Caenorhabditis elegans</italic></article-title>. <source/>Nature
<volume>391</volume>, <fpage>806</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1038/35888</pub-id><pub-id pub-id-type="pmid">9486653</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortini</surname><given-names>M.</given-names></name><name><surname>Skupski</surname><given-names>M.</given-names></name><name><surname>Boguski</surname><given-names>M.</given-names></name><name><surname>Hariharan</surname><given-names>I.</given-names></name></person-group> (<year>2000</year>). <article-title>A survey of human disease gene counterparts in the Drosophila genome</article-title>. <source/>J. Cell Biol.
<volume>150</volume>, <fpage>F23</fpage>–<lpage>F30</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.150.2.F23</pub-id><pub-id pub-id-type="pmid">10908582</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>L. M.</given-names></name><name><surname>Okray</surname><given-names>Z.</given-names></name><name><surname>Linneweber</surname><given-names>G. A.</given-names></name><name><surname>Hassan</surname><given-names>B. A.</given-names></name><name><surname>Yaksi</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Reduced lateral inhibition impairs olfactory computations and behaviors in a Drosophila model of fragile X syndrome</article-title>. <source/>Curr. Biol. <volume>27</volume>, <fpage>1111</fpage>–<lpage>1123</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2017.02.065</pub-id><pub-id pub-id-type="pmid">28366741</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>S. H.</given-names></name><name><surname>Dani</surname><given-names>N.</given-names></name><name><surname>Rushton</surname><given-names>E.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila</article-title>. <source/>Dis. Model. Mech.
<volume>6</volume>, <fpage>1400</fpage>–<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.012229</pub-id><pub-id pub-id-type="pmid">24046358</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gantois</surname><given-names>I.</given-names></name><name><surname>Vandesompele</surname><given-names>J.</given-names></name><name><surname>Speleman</surname><given-names>F.</given-names></name><name><surname>Reyniers</surname><given-names>E.</given-names></name><name><surname>D'Hooge</surname><given-names>R.</given-names></name><name><surname>Severijnen</surname><given-names>L.-A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model</article-title>. <source/>Neurobiol. Dis.
<volume>21</volume>, <fpage>346</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.07.017</pub-id><pub-id pub-id-type="pmid">16199166</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>K. B.</given-names></name><name><surname>Visootsak</surname><given-names>J.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Fragile X syndrome</article-title>. <source/>Eur. J. Hum. Genet.
<volume>16</volume>, <fpage>666</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.61</pub-id><pub-id pub-id-type="pmid">18398441</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure</article-title>. <source/>Development
<volume>135</volume>, <fpage>2637</fpage>–<lpage>2648</lpage>. <pub-id pub-id-type="doi">10.1242/dev.022244</pub-id><pub-id pub-id-type="pmid">18579676</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Temporal requirements of the fragile X mental retardation protein in modulating circadian clock circuit synaptic architecture</article-title>. <source/>Front. Neural Circuits
<volume>3</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.3389/neuro.04.008.2009</pub-id><pub-id pub-id-type="pmid">19738924</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons</article-title>. <source/>Dev. Biol.
<volume>356</volume>, <fpage>291</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2011.05.001</pub-id><pub-id pub-id-type="pmid">21596027</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Pereira</surname><given-names>D.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>GABAergic circuit dysfunction in the Drosophila fragile X syndrome model</article-title>. <source/>Neurobiol. Dis.
<volume>65</volume>, <fpage>142</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.01.008</pub-id><pub-id pub-id-type="pmid">24423648</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>C.-W.</given-names></name><name><surname>Kelly</surname><given-names>S. M.</given-names></name><name><surname>Bhattacharya</surname><given-names>A.</given-names></name><name><surname>McBride</surname><given-names>S. M. J.</given-names></name><name><surname>Danielson</surname><given-names>S. W.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome</article-title>. <source/>Cell Rep.
<volume>11</volume>, <fpage>727</fpage>–<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.060</pub-id><pub-id pub-id-type="pmid">25921541</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Günther</surname><given-names>M. N.</given-names></name><name><surname>Nettesheim</surname><given-names>G.</given-names></name><name><surname>Shubeita</surname><given-names>G. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Quantifying and predicting Drosophila larvae crawling phenotypes</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>27972</fpage>. <pub-id pub-id-type="doi">10.1038/srep27972</pub-id><pub-id pub-id-type="pmid">27323901</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The physical and behavioral phenotype</article-title>, in <source/>Fragile X Syndrome, Diagnosis, Treatment, and Research, eds <person-group person-group-type="editor"><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Hagerman</surname><given-names>P. J.</given-names></name></person-group> (<publisher-loc>Baltimore, MD</publisher-loc>: <publisher-name>John Hopkins University Press</publisher-name>), <fpage>3</fpage>–<lpage>109</lpage>.</mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Portes</surname><given-names>D. V.</given-names></name><name><surname>Gasparini</surname><given-names>F.</given-names></name><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Gomez-Mancilla</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Translating molecular advances in fragile X syndrome into therapy: a review</article-title>. <source/>J. Clin. Psychiatry
<volume>75</volume>, <fpage>e294</fpage>–<lpage>e307</lpage>. <pub-id pub-id-type="doi">10.4088/JCP.13r08714</pub-id><pub-id pub-id-type="pmid">24813413</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>D. A.</given-names></name><name><surname>Robertson</surname><given-names>E.</given-names></name><name><surname>Shelton</surname><given-names>A. L.</given-names></name><name><surname>Losh</surname><given-names>M. C.</given-names></name><name><surname>Milà</surname><given-names>M.</given-names></name><name><surname>Moreno</surname><given-names>E. G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Update on the clinical, radiographic, and neurobehavioral manifestations in FXTAS and FMR1 Premutation Carriers</article-title>. <source/>Cerebellum
<volume>15</volume>, <fpage>578</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-016-0799-4</pub-id><pub-id pub-id-type="pmid">27287737</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>S. M.</given-names></name><name><surname>Green</surname><given-names>J. R.</given-names></name><name><surname>Veeraragavan</surname><given-names>S.</given-names></name><name><surname>Yuva</surname><given-names>L.</given-names></name><name><surname>McCoy</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders</article-title>. <source/>Behav. Neurosci.
<volume>128</volume>, <fpage>103</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1037/a0035988</pub-id><pub-id pub-id-type="pmid">24773431</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>C. J.</given-names></name><name><surname>Jack</surname><given-names>E. M.</given-names></name><name><surname>Allen</surname><given-names>T. D.</given-names></name><name><surname>Harris</surname><given-names>R.</given-names></name></person-group> (<year>1983</year>). <article-title>The fragile X: a scanning electron microscope study</article-title>. <source/>J. Med. Genet.
<volume>20</volume>, <fpage>280</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.20.4.280</pub-id><pub-id pub-id-type="pmid">6684694</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>B. E.</given-names></name><name><surname>Kumari</surname><given-names>D.</given-names></name><name><surname>Usdin</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Recent advances in assays for the fragile X-related disorders</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>1313</fpage>–<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1840-5</pub-id><pub-id pub-id-type="pmid">28866801</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffer</surname><given-names>C. A.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Mu</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>D. V.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome</article-title>. <source/>Genes Brain Behav.
<volume>11</volume>, <fpage>332</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2012.00768.x</pub-id><pub-id pub-id-type="pmid">22268788</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Up-regulated cytoplasmic FMRP-interacting protein 1 in intractable temporal lobe epilepsy patients and a rat model</article-title>. <source/>Int. J. Neurosci.
<volume>126</volume>, <fpage>542</fpage>–<lpage>551</lpage>
<pub-id pub-id-type="doi">10.3109/00207454.2015.1038711</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>K. M.</given-names></name><name><surname>Gallagher</surname><given-names>S. M.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2002</year>). <article-title>Altered synaptic plasticity in a mouse model of fragile X mental retardation</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>99</volume>, <fpage>7746</fpage>–<lpage>7750</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.122205699</pub-id><pub-id pub-id-type="pmid">12032354</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutsler</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</article-title>. <source/>Brain Res.
<volume>1309</volume>, <fpage>83</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id><pub-id pub-id-type="pmid">19896929</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idrissi</surname><given-names>E. L. A.</given-names></name><name><surname>Ding</surname><given-names>X.-H.</given-names></name><name><surname>Scalia</surname><given-names>J.</given-names></name><name><surname>Trenkner</surname><given-names>E.</given-names></name><name><surname>Brown</surname><given-names>W. T.</given-names></name><name><surname>Dobkin</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse</article-title>. <source/>Neurosci. Lett.
<volume>377</volume>, <fpage>141</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2004.11.087</pub-id><pub-id pub-id-type="pmid">15755515</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>S.</given-names></name><name><surname>Shimoda</surname><given-names>M.</given-names></name><name><surname>Nishinokubi</surname><given-names>I.</given-names></name><name><surname>Siomi</surname><given-names>M. C.</given-names></name><name><surname>Okamura</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>A role for the Drosophila fragile X-related gene in circadian output</article-title>. <source/>Curr. Biol.
<volume>12</volume>, <fpage>1331</fpage>–<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(02)01036-9</pub-id><pub-id pub-id-type="pmid">12176363</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>S. A.</given-names></name><name><surname>Patel</surname><given-names>B.</given-names></name><name><surname>Idupulapati</surname><given-names>M.</given-names></name><name><surname>Harris</surname><given-names>J. B.</given-names></name><name><surname>Crisostomo</surname><given-names>R. A.</given-names></name><name><surname>Larsen</surname><given-names>B. P.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination</article-title>. <source/>Am. J. Med. Genet.
<volume>98</volume>, <fpage>161</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;161::AID-AJMG1025&gt;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">11223852</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Drosophila homolog of FMRP maintains genome integrity by interacting with piwi</article-title>. <source/>J. Genet. Genomics
<volume>43</volume>, <fpage>11</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgg.2015.11.001</pub-id><pub-id pub-id-type="pmid">26842990</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Pearson</surname><given-names>C. E.</given-names></name><name><surname>Lucchesi</surname><given-names>J. C.</given-names></name><name><surname>Moses</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Repeats in Drosophila</article-title>. <source/>Neuron
<volume>39</volume>, <fpage>739</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00533-6</pub-id><pub-id pub-id-type="pmid">12948442</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kacsoh</surname><given-names>B. Z.</given-names></name><name><surname>Bozler</surname><given-names>J.</given-names></name><name><surname>Hodge</surname><given-names>S.</given-names></name><name><surname>Ramaswami</surname><given-names>M.</given-names></name><name><surname>Bosco</surname><given-names>G.</given-names></name></person-group> (<year>2015a</year>). <article-title>A novel paradigm for nonassociative long-term memory in Drosophila: predator-induced changes in oviposition behavior</article-title>. <source/>Genetics
<volume>199</volume>, <fpage>1143</fpage>–<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.114.172221</pub-id><pub-id pub-id-type="pmid">25633088</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kacsoh</surname><given-names>B. Z.</given-names></name><name><surname>Bozler</surname><given-names>J.</given-names></name><name><surname>Ramaswami</surname><given-names>M.</given-names></name><name><surname>Bosco</surname><given-names>G.</given-names></name></person-group> (<year>2015b</year>). <article-title>Social communication of predator-induced changes in Drosophila behavior and germ line physiology</article-title>. <source/>Elife
<volume>13</volume>:<fpage>4</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.07423</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanellopoulos</surname><given-names>A. K.</given-names></name><name><surname>Semelidou</surname><given-names>O.</given-names></name><name><surname>Kotini</surname><given-names>A. G.</given-names></name><name><surname>Anezaki</surname><given-names>M.</given-names></name><name><surname>Skoulakis</surname><given-names>E. M. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Learning and memory deficits consequent to reduction of the fragile X mental retardation protein result from metabotropic glutamate receptor-mediated inhibition of cAMP signaling in Drosophila</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>13111</fpage>–<lpage>13124</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1347-12.2012</pub-id><pub-id pub-id-type="pmid">22993428</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashima</surname><given-names>R.</given-names></name><name><surname>Redmond</surname><given-names>P. L.</given-names></name><name><surname>Ghatpande</surname><given-names>P.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Kornberg</surname><given-names>T. B.</given-names></name><name><surname>Hanke</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Hyperactive locomotion in a Drosophila model is a functional readout for the synaptic abnormalities underlying fragile X syndrome</article-title>. <source/>Sci. Signal.
<volume>10</volume>:<fpage>eaai8133</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.aai8133</pub-id><pub-id pub-id-type="pmid">28465421</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashima</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Ascano</surname><given-names>M.</given-names></name><name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name><name><surname>Ariza-Torres</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome</article-title>. <source/>Sci. Signal.
<volume>9</volume>:<fpage>ra58</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.aaf6060</pub-id><pub-id pub-id-type="pmid">27273096</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>K.</given-names></name><name><surname>Chang</surname><given-names>S.-J. E.</given-names></name><name><surname>Lin</surname><given-names>S.-L.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanism of repeat-associated microRNAs in fragile X syndrome</article-title>. <source/>Neural Plast.
<volume>2012</volume>:<fpage>104796</fpage>. <pub-id pub-id-type="doi">10.1155/2012/104796</pub-id><pub-id pub-id-type="pmid">22779005</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>T.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Fragile X mental retardation protein restricts small dye iontophoresis entry into central neurons</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>9844</fpage>–<lpage>9858</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0723-17.2017</pub-id><pub-id pub-id-type="pmid">28887386</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandjian</surname><given-names>E. W.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Corbin</surname><given-names>F.</given-names></name><name><surname>Sittler</surname><given-names>A.</given-names></name><name><surname>Giroux</surname><given-names>S.</given-names></name><name><surname>Heitz</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis</article-title>. <source/>Hum. Mol. Genet. <volume>7</volume>, <fpage>2121</fpage>–<lpage>2128</lpage>. <pub-id pub-id-type="pmid">9817930</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandjian</surname><given-names>E. W.</given-names></name><name><surname>Huot</surname><given-names>M.-E.</given-names></name><name><surname>Tremblay</surname><given-names>S.</given-names></name><name><surname>Davidovic</surname><given-names>L.</given-names></name><name><surname>Mazroui</surname><given-names>R.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>101</volume>, <fpage>13357</fpage>–<lpage>13362</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0405398101</pub-id><pub-id pub-id-type="pmid">15329415</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidd</surname><given-names>S. A.</given-names></name><name><surname>Lachiewicz</surname><given-names>A.</given-names></name><name><surname>Barbouth</surname><given-names>D.</given-names></name><name><surname>Blitz</surname><given-names>R. K.</given-names></name><name><surname>Delahunty</surname><given-names>C.</given-names></name><name><surname>McBrien</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Fragile X syndrome: a review of associated medical problems</article-title>. <source/>Pediatrics
<volume>134</volume>, <fpage>995</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2013-4301</pub-id><pub-id pub-id-type="pmid">25287458</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Coolon</surname><given-names>R.</given-names></name><name><surname>Ye</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Dscam expression levels determine presynaptic arbor sizes in Drosophila sensory neurons</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>827</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.020</pub-id><pub-id pub-id-type="pmid">23764288</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Maaswinkel</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Sirotkin</surname><given-names>H.</given-names></name><name><surname>Weng</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Anxiety, hyperactivity and stereotypy in a zebrafish model of fragile X syndrome and autism spectrum disorder</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>55</volume>, <fpage>40</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2014.03.007</pub-id><pub-id pub-id-type="pmid">24681195</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>M.-G.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Song</surname><given-names>Q.</given-names></name><name><surname>O'Den</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Impaired presynaptic long-term potentiation in the anterior cingulate cortex of Fmr1 knock-out mice</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>2033</fpage>–<lpage>2043</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2644-14.2015</pub-id><pub-id pub-id-type="pmid">25653361</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>P. O.</given-names></name><name><surname>Undie</surname><given-names>A. S.</given-names></name><name><surname>Kabbani</surname><given-names>N.</given-names></name><name><surname>Levenson</surname><given-names>R.</given-names></name><name><surname>Goldman-Rakic</surname><given-names>P. S.</given-names></name><name><surname>Lidow</surname><given-names>M. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>313</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.232693499</pub-id><pub-id pub-id-type="pmid">12496348</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krashes</surname><given-names>M. J.</given-names></name><name><surname>Keene</surname><given-names>A. C.</given-names></name><name><surname>Leung</surname><given-names>B.</given-names></name><name><surname>Armstrong</surname><given-names>J. D.</given-names></name><name><surname>Waddell</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Sequential use of mushroom body neuron subsets during Drosophila odor memory processing</article-title>. <source/>Neuron
<volume>53</volume>, <fpage>103</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.11.021</pub-id><pub-id pub-id-type="pmid">17196534</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Bogert</surname><given-names>B. A.</given-names></name><name><surname>Su</surname><given-names>K.</given-names></name><name><surname>Gao</surname><given-names>F.-B.</given-names></name></person-group> (<year>2003</year>). <article-title>Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1</article-title>. <source/>Development
<volume>130</volume>, <fpage>5543</fpage>–<lpage>5552</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00792</pub-id><pub-id pub-id-type="pmid">14530299</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Zabolotny</surname><given-names>J. M.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Insulin in the nervous system and the mind: functions in metabolism, memory, and mood</article-title>. <source/>Mol. Metab.
<volume>5</volume>, <fpage>589</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2016.06.011</pub-id><pub-id pub-id-type="pmid">27656397</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee-Hoeflich</surname><given-names>S. T.</given-names></name><name><surname>Causing</surname><given-names>C. G.</given-names></name><name><surname>Podkowa</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Wrana</surname><given-names>J. L.</given-names></name><name><surname>Attisano</surname><given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis</article-title>. <source/>EMBO J.
<volume>23</volume>, <fpage>4792</fpage>–<lpage>4801</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600418</pub-id><pub-id pub-id-type="pmid">15538389</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limmer</surname><given-names>S.</given-names></name><name><surname>Weiler</surname><given-names>A.</given-names></name><name><surname>Volkenhoff</surname><given-names>A.</given-names></name><name><surname>Babatz</surname><given-names>F.</given-names></name><name><surname>Klämbt</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>The Drosophila blood-brain barrier: development and function of a glial endothelium</article-title>. <source/>Front. Neurosci.
<volume>8</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2014.00365</pub-id><pub-id pub-id-type="pmid">24624055</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>Niswander</surname><given-names>L. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Bone morphogenetic protein signalling and vertebrate nervous system development</article-title>. <source/>Nat. Rev. Neurosci.
<volume>6</volume>, <fpage>945</fpage>–<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1805</pub-id><pub-id pub-id-type="pmid">16340955</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>M. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Fragile phagocytes: FMRP positively regulates engulfment activity</article-title>. <source/>J. Cell Biol.
<volume>216</volume>, <fpage>531</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201702034</pub-id><pub-id pub-id-type="pmid">28228533</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>CMP-N-acetylneuraminic acid synthetase interacts with fragile X related protein 1</article-title>. <source/>Mol. Med. Rep.
<volume>14</volume>, <fpage>1501</fpage>–<lpage>1508</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2016.5438</pub-id><pub-id pub-id-type="pmid">27357083</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madrigal</surname><given-names>I.</given-names></name><name><surname>Rodríguez-Revenga</surname><given-names>L.</given-names></name><name><surname>Xunclà</surname><given-names>M.</given-names></name><name><surname>Milà</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>15q11.2 microdeletion and FMR1 premutation in a family with intellectual disabilities and autism</article-title>. <source/>Gene
<volume>508</volume>, <fpage>92</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.07.023</pub-id><pub-id pub-id-type="pmid">22842191</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansilla</surname><given-names>A.</given-names></name><name><surname>Chaves-Sanjuan</surname><given-names>A.</given-names></name><name><surname>Campillo</surname><given-names>N. E.</given-names></name><name><surname>Semelidou</surname><given-names>O.</given-names></name><name><surname>Martínez-González</surname><given-names>L.</given-names></name><name><surname>Infantes</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A. <volume>114</volume>, <fpage>E999</fpage>–<lpage>E1008</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1611089114</pub-id><pub-id pub-id-type="pmid">28119500</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>V. G.</given-names></name><name><surname>Javadi</surname><given-names>C. S.</given-names></name><name><surname>Ngo</surname><given-names>E.</given-names></name><name><surname>Ngo</surname><given-names>L.</given-names></name><name><surname>Lagow</surname><given-names>R. D.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Age-related changes in climbing behavior and neural circuit physiology in Drosophila</article-title>. <source/>Dev. Neurobiol.
<volume>67</volume>, <fpage>778</fpage>–<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20388</pub-id><pub-id pub-id-type="pmid">17443824</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurin</surname><given-names>T.</given-names></name><name><surname>Zongaro</surname><given-names>S.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Fragile X syndrome: from molecular pathology to therapy</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>46</volume>(<issue>Pt 2</issue>), <fpage>242</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.01.006</pub-id><pub-id pub-id-type="pmid">24462888</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBrayer</surname><given-names>Z. L.</given-names></name><name><surname>Dimova</surname><given-names>J.</given-names></name><name><surname>Pisansky</surname><given-names>M. T.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Beppu</surname><given-names>H.</given-names></name><name><surname>Gewirtz</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Forebrain-specific loss of BMPRII in mice reduces anxiety and increases object exploration</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0139860</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0139860</pub-id><pub-id pub-id-type="pmid">26444546</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>S. M. J.</given-names></name><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liebelt</surname><given-names>D.</given-names></name><name><surname>Braunstein</surname><given-names>E.</given-names></name><name><surname>Ferreiro</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome</article-title>. <source/>Neuron
<volume>45</volume>, <fpage>753</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.01.038</pub-id><pub-id pub-id-type="pmid">15748850</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megosh</surname><given-names>H. B.</given-names></name><name><surname>Cox</surname><given-names>D. N.</given-names></name><name><surname>Campbell</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of PIWI and the miRNA machinery in Drosophila germline determination</article-title>. <source/>Curr. Biol.
<volume>16</volume>, <fpage>1884</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2006.08.051</pub-id><pub-id pub-id-type="pmid">16949822</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Tregoubov</surname><given-names>V.</given-names></name><name><surname>Janus</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>L.</given-names></name><name><surname>Jackson</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice</article-title>. <source/>Neuron
<volume>35</volume>, <fpage>121</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00758-4</pub-id><pub-id pub-id-type="pmid">12123613</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>K. P.</given-names></name><name><surname>Carrillo</surname><given-names>R. A.</given-names></name><name><surname>Zinn</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Development and plasticity of the Drosophila larval neuromuscular junction</article-title>. <source/>Wiley Interdiscip. Rev. Dev. Biol.
<volume>2</volume>, <fpage>647</fpage>–<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.108</pub-id><pub-id pub-id-type="pmid">24014452</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>C. I.</given-names></name><name><surname>Kraft</surname><given-names>R.</given-names></name><name><surname>Restifo</surname><given-names>L. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>5798</fpage>–<lpage>5809</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1102-04.2004</pub-id><pub-id pub-id-type="pmid">15215302</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mientjes</surname><given-names>E. J.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>I.</given-names></name><name><surname>Kirkpatrick</surname><given-names>L.</given-names></name><name><surname>Zu</surname><given-names>T.</given-names></name><name><surname>Hoogeveen-Westerveld</surname><given-names>M.</given-names></name><name><surname>Severijnen</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>The generation of a conditional Fmr1 knock out mouse model to study Fmrp function <italic>in vivo</italic></article-title>. <source/>Neurobiol. Dis.
<volume>21</volume>, <fpage>549</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.08.019</pub-id><pub-id pub-id-type="pmid">16257225</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mientjes</surname><given-names>E. J.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Kirkpatrick</surname><given-names>L. L.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>I. M.</given-names></name><name><surname>Hoogeveen-Westerveld</surname><given-names>M.</given-names></name><name><surname>Verweij</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function <italic>in vivo</italic></article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>1291</fpage>–<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh150</pub-id><pub-id pub-id-type="pmid">15128702</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyashiro</surname><given-names>K. Y.</given-names></name><name><surname>Beckel-Mitchener</surname><given-names>A.</given-names></name><name><surname>Purk</surname><given-names>T. P.</given-names></name><name><surname>Becker</surname><given-names>K. G.</given-names></name><name><surname>Barret</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice</article-title>. <source/>Neuron
<volume>37</volume>, <fpage>417</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00034-5</pub-id><pub-id pub-id-type="pmid">12575950</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monyak</surname><given-names>R. E.</given-names></name><name><surname>Emerson</surname><given-names>D.</given-names></name><name><surname>Schoenfeld</surname><given-names>B. P.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Chambers</surname><given-names>D. B.</given-names></name><name><surname>Rosenfelt</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model</article-title>. <source/>Mol. Psychiatry
<volume>22</volume>, <fpage>1140</fpage>–<lpage>1148</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.51</pub-id><pub-id pub-id-type="pmid">27090306</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monzo</surname><given-names>K.</given-names></name><name><surname>Papoulas</surname><given-names>O.</given-names></name><name><surname>Cantin</surname><given-names>G. T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names></name><name><surname>Sisson</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>103</volume>, <fpage>18160</fpage>–<lpage>18165</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0606508103</pub-id><pub-id pub-id-type="pmid">17110444</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J.</given-names></name><name><surname>Hiesinger</surname><given-names>P. R.</given-names></name><name><surname>Schroeder</surname><given-names>A. J.</given-names></name><name><surname>Kume</surname><given-names>K.</given-names></name><name><surname>Verstreken</surname><given-names>P.</given-names></name><name><surname>Jackson</surname><given-names>F. R.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain</article-title>. <source/>Neuron
<volume>34</volume>, <fpage>961</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00731-6</pub-id><pub-id pub-id-type="pmid">12086643</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myrick</surname><given-names>L. K.</given-names></name><name><surname>Deng</surname><given-names>P.-Y.</given-names></name><name><surname>Hashimoto</surname><given-names>H.</given-names></name><name><surname>Oh</surname><given-names>Y. M.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Poidevin</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>949</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1423094112</pub-id><pub-id pub-id-type="pmid">25561520</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>M.-C.</given-names></name><name><surname>Yang</surname><given-names>Y.-L.</given-names></name><name><surname>Lu</surname><given-names>K.-T.</given-names></name></person-group> (<year>2013</year>). <article-title>Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e51456</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051456</pub-id><pub-id pub-id-type="pmid">23536755</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>P.</given-names></name><name><surname>Seo</surname><given-names>J. B.</given-names></name><name><surname>Ahn</surname><given-names>H.-M.</given-names></name><name><surname>Koh</surname><given-names>Y. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Drosophila torsin protein regulates motor control and stress sensitivity and forms a complex with Fragile-X mental retardation protein</article-title>. <source/>Neural Plast.
<volume>2016</volume>:<fpage>6762086</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6762086</pub-id><pub-id pub-id-type="pmid">27313903</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>S. M.</given-names></name><name><surname>Joardar</surname><given-names>A.</given-names></name><name><surname>Gregorio</surname><given-names>C. C.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Regulation of heart rate in drosophila via fragile X mental retardation protein</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0142836</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142836</pub-id><pub-id pub-id-type="pmid">26571124</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowicki</surname><given-names>S. T.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Ono</surname><given-names>M. Y.</given-names></name><name><surname>Ferranti</surname><given-names>J.</given-names></name><name><surname>Croquette</surname><given-names>M. F.</given-names></name><name><surname>Goodlin-Jones</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>The Prader-Willi phenotype of fragile X syndrome</article-title>. <source/>J. Dev. Behav. Pediatr.
<volume>28</volume>, <fpage>133</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1097/01.DBP.0000267563.18952.c9</pub-id><pub-id pub-id-type="pmid">17435464</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>R. M.</given-names></name><name><surname>Stone</surname><given-names>E. F.</given-names></name><name><surname>Wayne</surname><given-names>C. R.</given-names></name><name><surname>Marcinkevicius</surname><given-names>E. V.</given-names></name><name><surname>Ulgherait</surname><given-names>M.</given-names></name><name><surname>Delventhal</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A Drosophila model of Fragile X syndrome exhibits defects in phagocytosis by innate immune cells</article-title>. <source/>J. Cell Biol. <volume>216</volume>, <fpage>595</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201607093</pub-id><pub-id pub-id-type="pmid">28223318</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okray</surname><given-names>Z.</given-names></name><name><surname>de Esch</surname><given-names>C. E. F.</given-names></name><name><surname>Van Esch</surname><given-names>H.</given-names></name><name><surname>Devriendt</surname><given-names>K.</given-names></name><name><surname>Claeys</surname><given-names>A.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function</article-title>. <source/>EMBO Mol. Med.
<volume>7</volume>, <fpage>423</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201404576</pub-id><pub-id pub-id-type="pmid">25693964</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y. Q.</given-names></name><name><surname>Woodruff</surname><given-names>E.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation</article-title>. <source/>Curr. Biol.
<volume>14</volume>, <fpage>1863</fpage>–<lpage>1870</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.09.085</pub-id><pub-id pub-id-type="pmid">15498496</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>U. B.</given-names></name><name><surname>Nichols</surname><given-names>C. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Human disease models in <italic>Drosophila melanogaster</italic> and the role of the fly in therapeutic drug discovery</article-title>. <source/>Pharmacol. Rev.
<volume>63</volume>, <fpage>441</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1124/pr.110.003293</pub-id><pub-id pub-id-type="pmid">21415126</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papoulas</surname><given-names>O.</given-names></name><name><surname>Monzo</surname><given-names>K. F.</given-names></name><name><surname>Cantin</surname><given-names>G. T.</given-names></name><name><surname>Ruse</surname><given-names>C.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names></name><name><surname>Ryu</surname><given-names>Y. H.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>dFMRP and Caprin, translational regulators of synaptic plasticity, control the cell cycle at the Drosophila mid-blastula transition</article-title>. <source/>Development
<volume>137</volume>, <fpage>4201</fpage>–<lpage>4209</lpage>. <pub-id pub-id-type="doi">10.1242/dev.055046</pub-id><pub-id pub-id-type="pmid">21068064</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penagarikano</surname><given-names>O.</given-names></name><name><surname>Mulle</surname><given-names>J. G.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2007</year>). <article-title>The pathophysiology of fragile x syndrome</article-title>. <source/>Annu. Rev. Genomics Hum. Genet.
<volume>8</volume>, <fpage>109</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.8.080706.092249</pub-id><pub-id pub-id-type="pmid">17477822</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepper</surname><given-names>A. S.-R.</given-names></name><name><surname>Beerman</surname><given-names>R. W.</given-names></name><name><surname>Bhogal</surname><given-names>B.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e7618</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007618</pub-id><pub-id pub-id-type="pmid">19888420</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccin</surname><given-names>A.</given-names></name><name><surname>Salameh</surname><given-names>A.</given-names></name><name><surname>Benna</surname><given-names>C.</given-names></name><name><surname>Sandrelli</surname><given-names>F.</given-names></name><name><surname>Mazzotta</surname><given-names>G.</given-names></name><name><surname>Zordan</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Efficient and heritable functional knock-out of an adult phenotype in Drosophila using a GAL4-driven hairpin RNA incorporating a heterologous spacer</article-title>. <source/>Nucleic Acids Res.
<volume>29</volume>, <fpage>e55</fpage>–<lpage>e55</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.12.e55</pub-id><pub-id pub-id-type="pmid">11410678</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinsonneault</surname><given-names>R. L.</given-names></name><name><surname>Mayer</surname><given-names>N.</given-names></name><name><surname>Mayer</surname><given-names>F.</given-names></name><name><surname>Tegegn</surname><given-names>N.</given-names></name><name><surname>Bainton</surname><given-names>R. J.</given-names></name></person-group>. (<year>2011</year>). <article-title>Novel models for studying the blood-brain and blood-eye barriers in <italic>Drosophila</italic></article-title>. <source/>Methods Mol. Biol.
<volume>686</volume>, <fpage>357</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-938-3_17</pub-id><pub-id pub-id-type="pmid">21082381</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piton</surname><given-names>A.</given-names></name><name><surname>Michaud</surname><given-names>J. L.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Aradhya</surname><given-names>S.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Mottron</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Mutations in the calcium-related gene IL1RAPL1 are associated with autism</article-title>. <source/>Hum. Mol. Genet.
<volume>17</volume>, <fpage>3965</fpage>–<lpage>3974</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn300</pub-id><pub-id pub-id-type="pmid">18801879</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyronneau</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Hwang</surname><given-names>J.-Y.</given-names></name><name><surname>Porch</surname><given-names>M.</given-names></name><name><surname>Contractor</surname><given-names>A.</given-names></name><name><surname>Zukin</surname><given-names>R. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome</article-title>. <source/>Sci. Signal.
<volume>10</volume>:<fpage>eaan0852</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.aan0852</pub-id><pub-id pub-id-type="pmid">29114038</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qurashi</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Ray</surname><given-names>L.</given-names></name><name><surname>Nelson</surname><given-names>D. L.</given-names></name><name><surname>Duan</surname><given-names>R.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila</article-title>. <source/>Hum. Mol. Genet.
<volume>21</volume>, <fpage>2068</fpage>–<lpage>2075</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds024</pub-id><pub-id pub-id-type="pmid">22298836</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeve</surname><given-names>S. P.</given-names></name><name><surname>Bassetto</surname><given-names>L.</given-names></name><name><surname>Genova</surname><given-names>G. K.</given-names></name><name><surname>Kleyner</surname><given-names>Y.</given-names></name><name><surname>Leyssen</surname><given-names>M.</given-names></name><name><surname>Jackson</surname><given-names>F. R.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain</article-title>. <source/>Curr. Biol.
<volume>15</volume>, <fpage>1156</fpage>–<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2005.05.050</pub-id><pub-id pub-id-type="pmid">15964283</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeve</surname><given-names>S. P.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Sahin</surname><given-names>B. H.</given-names></name><name><surname>Jiang</surname><given-names>F.</given-names></name><name><surname>Yao</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>3221</fpage>–<lpage>3226</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5528-07.2008</pub-id><pub-id pub-id-type="pmid">18354025</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Pozuelo</surname><given-names>J.</given-names></name><name><surname>Dason</surname><given-names>J. S.</given-names></name><name><surname>Mansilla</surname><given-names>A.</given-names></name><name><surname>Baños-Mateos</surname><given-names>S.</given-names></name><name><surname>Sardina</surname><given-names>J. L.</given-names></name><name><surname>Chaves-Sanjuan</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The guanine-exchange factor Ric8a binds to the Ca<sup>2+</sup> sensor NCS-1 to regulate synapse number and neurotransmitter release</article-title>. <source/>J. Cell Sci.
<volume>127</volume>, <fpage>4246</fpage>–<lpage>4259</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.152603</pub-id><pub-id pub-id-type="pmid">25074811</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabanov</surname><given-names>V.</given-names></name><name><surname>Braat</surname><given-names>S.</given-names></name><name><surname>D'Andrea</surname><given-names>L.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Zeidler</surname><given-names>S.</given-names></name><name><surname>Rooms</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice</article-title>. <source/>Neuropharmacology
<volume>116</volume>, <fpage>71</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.12.010</pub-id><pub-id pub-id-type="pmid">28012946</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>M. R.</given-names></name><name><surname>Bray</surname><given-names>S. M.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective</article-title>. <source/>Annu. Rev. Pathol.
<volume>7</volume>, <fpage>219</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id><pub-id pub-id-type="pmid">22017584</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>T. L.</given-names></name><name><surname>Davenport</surname><given-names>M. H.</given-names></name><name><surname>Erickson</surname><given-names>C. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging pharmacologic treatment options for fragile X syndrome</article-title>. <source/>Appl. Clin. Genet.
<volume>8</volume>, <fpage>75</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.2147/TACG.S35673</pub-id><pub-id pub-id-type="pmid">25897255</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenck</surname><given-names>A.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Langmann</surname><given-names>C.</given-names></name><name><surname>Harden</surname><given-names>N.</given-names></name><name><surname>Mandel</surname><given-names>J.</given-names></name><name><surname>Giangrande</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein</article-title>. <source/>Neuron
<volume>38</volume>, <fpage>887</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00354-4</pub-id><pub-id pub-id-type="pmid">12818175</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenck</surname><given-names>A.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Moro</surname><given-names>A.</given-names></name><name><surname>Bagni</surname><given-names>C.</given-names></name><name><surname>Mandel</surname><given-names>J. L.</given-names></name></person-group> (<year>2001</year>). <article-title>A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>98</volume>, <fpage>8844</fpage>–<lpage>8849</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.151231598</pub-id><pub-id pub-id-type="pmid">11438699</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenck</surname><given-names>A.</given-names></name><name><surname>Van de Bor</surname><given-names>V.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Giangrande</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Novel features of dFMR1, the Drosophila orthologue of the fragile X mental retardation protein</article-title>. <source/>Neurobiol. Dis.
<volume>11</volume>, <fpage>53</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.2002.0510</pub-id><pub-id pub-id-type="pmid">12460546</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S. L.</given-names></name><name><surname>Curnow</surname><given-names>E. C.</given-names></name><name><surname>Easley</surname><given-names>C. A.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Hukema</surname><given-names>R. K.</given-names></name><name><surname>Tejada</surname><given-names>M. I.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)</article-title>. <source/>J. Neurodev. Disord.
<volume>6</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1186/1866-1955-6-26</pub-id><pub-id pub-id-type="pmid">25147583</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siller</surname><given-names>S. S.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase</article-title>. <source/>Dis. Model. Mech.
<volume>4</volume>, <fpage>673</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.008045</pub-id><pub-id pub-id-type="pmid">21669931</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>E. M.</given-names></name><name><surname>Bertelsen</surname><given-names>F.</given-names></name><name><surname>Weikop</surname><given-names>P.</given-names></name><name><surname>Skovborg</surname><given-names>M. M.</given-names></name><name><surname>Banke</surname><given-names>T.</given-names></name><name><surname>Drasbek</surname><given-names>K. R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse</article-title>. <source/>Behav. Pharmacol.
<volume>26</volume>, <fpage>733</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0000000000000152</pub-id><pub-id pub-id-type="pmid">26110222</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Specchia</surname><given-names>V.</given-names></name><name><surname>D'Attis</surname><given-names>S.</given-names></name><name><surname>Puricella</surname><given-names>A.</given-names></name><name><surname>Bozzetti</surname><given-names>M. P.</given-names></name></person-group> (<year>2017</year>). <article-title>dFmr1 plays roles in small RNA pathways of <italic>Drosophila melanogaster</italic></article-title>. <source/>Int. J. Mol. Sci.
<volume>18</volume>:<fpage>E1066</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18051066</pub-id><pub-id pub-id-type="pmid">28509881</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>G. R.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Ye</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors</article-title>. <source/>Elife
<volume>4</volume>:<fpage>e05196</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.05196</pub-id><pub-id pub-id-type="pmid">25988807</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhakaran</surname><given-names>I. P.</given-names></name><name><surname>Hillebrand</surname><given-names>J.</given-names></name><name><surname>Dervan</surname><given-names>A.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Holohan</surname><given-names>E. E.</given-names></name><name><surname>Hülsmeier</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>111</volume>, <fpage>E99</fpage>–<lpage>E108</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1309543111</pub-id><pub-id pub-id-type="pmid">24344294</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenawa</surname><given-names>T.</given-names></name><name><surname>Suetsugu</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>The WASP-WAVE protein network: connecting the membrane to the cytoskeleton</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>8</volume>, <fpage>37</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2069</pub-id><pub-id pub-id-type="pmid">17183359</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauber</surname><given-names>J. M.</given-names></name><name><surname>Vanlandingham</surname><given-names>P. A.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e27100</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0027100</pub-id><pub-id pub-id-type="pmid">22087250</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessier</surname><given-names>C. R.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning</article-title>. <source/>Development
<volume>135</volume>, <fpage>1547</fpage>–<lpage>1557</lpage>. <pub-id pub-id-type="doi">10.1242/dev.015867</pub-id><pub-id pub-id-type="pmid">18321984</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessier</surname><given-names>C. R.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons</article-title>. <source/>Neurobiol. Dis.
<volume>41</volume>, <fpage>147</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.09.002</pub-id><pub-id pub-id-type="pmid">20843478</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tevy</surname><given-names>M. F.</given-names></name><name><surname>Seyres</surname><given-names>D.</given-names></name><name><surname>Traina</surname><given-names>C.</given-names></name><name><surname>Perrin</surname><given-names>L.</given-names></name><name><surname>Capovilla</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Ndae1 expression and regulation in Drosophila embryos</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e92956</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0092956</pub-id><pub-id pub-id-type="pmid">24676142</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The Dutch-Belgian Fragile X Consortium</collab></person-group> (<year>1994</year>). <article-title>Fmr1 knockout mice: a model to study fragile X mental retardation</article-title>. <source/>Cell
<volume>78</volume>, <fpage>23</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">8033209</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Shang</surname><given-names>S.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Loss of FMRP impaired hippocampal long-term plasticity and spatial learning in rats</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>:<fpage>269</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00269</pub-id><pub-id pub-id-type="pmid">28894415</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>K. C. L.</given-names></name><name><surname>Souza</surname><given-names>B. R.</given-names></name><name><surname>Miranda</surname><given-names>D. M.</given-names></name><name><surname>Sampaio</surname><given-names>A. M.</given-names></name><name><surname>Nicolato</surname><given-names>R.</given-names></name><name><surname>Neves</surname><given-names>F. S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>33</volume>, <fpage>229</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2008.11.011</pub-id><pub-id pub-id-type="pmid">19091302</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truszkowski</surname><given-names>T. L. S.</given-names></name><name><surname>James</surname><given-names>E. J.</given-names></name><name><surname>Hasan</surname><given-names>M.</given-names></name><name><surname>Wishard</surname><given-names>T. J.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Pratt</surname><given-names>K. G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Fragile X mental retardation protein knockdown in the developing Xenopus tadpole optic tectum results in enhanced feedforward inhibition and behavioral deficits</article-title>. <source/>Neural Dev.
<volume>11</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s13064-016-0069-7</pub-id><pub-id pub-id-type="pmid">27503008</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>B.</given-names></name><name><surname>Richards</surname><given-names>R. I.</given-names></name><name><surname>Lardelli</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>15</volume>, <fpage>3446</fpage>–<lpage>3458</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl422</pub-id><pub-id pub-id-type="pmid">17065172</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugur</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Drosophila tools and assays for the study of human diseases</article-title>. <source/>Dis. Model. Mech.
<volume>9</volume>, <fpage>235</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.023762</pub-id><pub-id pub-id-type="pmid">26935102</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utari</surname><given-names>A.</given-names></name><name><surname>Adams</surname><given-names>E.</given-names></name><name><surname>Berry-Kravis</surname><given-names>E.</given-names></name><name><surname>Chavez</surname><given-names>A.</given-names></name><name><surname>Scaggs</surname><given-names>F.</given-names></name><name><surname>Ngotran</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Aging in fragile X syndrome</article-title>. <source/>J. Neurodev. Disord.
<volume>2</volume>, <fpage>70</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s11689-010-9047-2</pub-id><pub-id pub-id-type="pmid">20585378</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Alphen</surname><given-names>B.</given-names></name><name><surname>van Swinderen</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Drosophila strategies to study psychiatric disorders</article-title>. <source/>Brain Res. Bull.
<volume>92</volume>, <fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.09.007</pub-id><pub-id pub-id-type="pmid">21978945</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Alphen</surname><given-names>B.</given-names></name><name><surname>Yap</surname><given-names>M. H. W.</given-names></name><name><surname>Kirszenblat</surname><given-names>L.</given-names></name><name><surname>Kottler</surname><given-names>B.</given-names></name><name><surname>van Swinderen</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>A dynamic deep sleep stage in Drosophila</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>6917</fpage>–<lpage>6927</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0061-13.2013</pub-id><pub-id pub-id-type="pmid">23595750</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van't Padje</surname><given-names>S.</given-names></name><name><surname>Chaudhry</surname><given-names>B.</given-names></name><name><surname>Severijnen</surname><given-names>L. A.</given-names></name><name><surname>van der Linde</surname><given-names>H. C.</given-names></name><name><surname>Mientjes</surname><given-names>E. J.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Reduction in fragile X related 1 protein causes cardiomyopathy and muscular dystrophy in zebrafish</article-title>. <source/>J. Exp. Biol.
<volume>212</volume>, <fpage>2564</fpage>–<lpage>2570</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.032532</pub-id>. <pub-id pub-id-type="pmid">19648401</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A. J.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Kuhl</surname><given-names>D. P.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome</article-title>. <source/>Cell
<volume>65</volume>, <fpage>905</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-H</pub-id><pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltes</surname><given-names>R.</given-names></name><name><surname>Duketis</surname><given-names>E.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Anney</surname><given-names>R. J. L.</given-names></name><name><surname>Huguet</surname><given-names>G.</given-names></name><name><surname>Schlitt</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders</article-title>. <source/>Hum. Genet.
<volume>133</volume>, <fpage>781</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1416-y</pub-id><pub-id pub-id-type="pmid">24442360</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name><name><surname>Dreyfuss</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Characterization of dFMR1, a <italic>Drosophila melanogaster</italic> homolog of the fragile X mental retardation protein</article-title>. <source/>Mol. Cell. Biol.
<volume>20</volume>, <fpage>8536</fpage>–<lpage>8547</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.20.22.8536-8547.2000</pub-id><pub-id pub-id-type="pmid">11046149</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Ott</surname><given-names>J.</given-names></name><name><surname>Saffen</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Common regulatory variants of CYFIP1 contribute to susceptibility for Autism Spectrum Disorder (ASD) and Classical Autism</article-title>. <source/>Ann. Hum. Genet.
<volume>79</volume>, <fpage>329</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1111/ahg.12121</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangler</surname><given-names>M. F.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Fruit flies in biomedical research</article-title>. <source/>Genetics
<volume>199</volume>, <fpage>639</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.114.171785</pub-id><pub-id pub-id-type="pmid">25624315</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisz</surname><given-names>E. D.</given-names></name><name><surname>Monyak</surname><given-names>R. E.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Deciphering discord: how Drosophila research has enhanced our understanding of the importance of FMRP in different spatial and temporal contexts</article-title>. <source/>Exp. Neurol.
<volume>274</volume>, <fpage>14</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.05.015</pub-id><pub-id pub-id-type="pmid">26026973</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.-J.</given-names></name><name><surname>Hsu</surname><given-names>M.-T.</given-names></name><name><surname>Ng</surname><given-names>M.-C.</given-names></name><name><surname>Amstislavskaya</surname><given-names>T. G.</given-names></name><name><surname>Tikhonova</surname><given-names>M. A.</given-names></name><name><surname>Yang</surname><given-names>Y.-L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Fragile X mental retardation-1 knockout zebrafish shows precocious development in social behavior</article-title>. <source/>Zebrafish
<volume>14</volume>, <fpage>438</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1089/zeb.2017.1446</pub-id><pub-id pub-id-type="pmid">28829283</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Bogert</surname><given-names>B. A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Su</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Gao</surname><given-names>F.-B.</given-names></name></person-group> (<year>2004</year>). <article-title>The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1</article-title>. <source/>Curr. Biol.
<volume>14</volume>, <fpage>1025</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.05.055</pub-id><pub-id pub-id-type="pmid">15202995</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Poidevin</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>E.</given-names></name><name><surname>Bi</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Circadian rhythm-dependent alterations of gene expression in Drosophila brain lacking fragile X mental retardation protein</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e37937</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0037937</pub-id><pub-id pub-id-type="pmid">22655085</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.-L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Gao</surname><given-names>F.-B.</given-names></name></person-group> (<year>2008</year>). <article-title>The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>11883</fpage>–<lpage>11889</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4114-08.2008</pub-id><pub-id pub-id-type="pmid">19005053</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Xia</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>The bantam microRNA is associated with drosophila fragile X mental retardation protein and regulates the fate of germline stem cells</article-title>. <source/>PLoS Genet.
<volume>5</volume>:<fpage>e1000444</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000444</pub-id><pub-id pub-id-type="pmid">19343200</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Betschinger</surname><given-names>J.</given-names></name><name><surname>Nakamoto</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Fragile X protein functions with lgl and the par complex in flies and mice</article-title>. <source/>Dev. Cell
<volume>8</volume>, <fpage>43</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2004.10.020</pub-id><pub-id pub-id-type="pmid">15621528</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Abdelmohsen</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Tominaga-Yamanaka</surname><given-names>K.</given-names></name><name><surname>Yoon</surname><given-names>J.-H.</given-names></name><name><surname>Ioannis</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Novel RNA- and FMRP-binding protein TRF2-S regulates axonal mRNA transport and presynaptic plasticity</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>8888</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9888</pub-id><pub-id pub-id-type="pmid">26586091</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>A feed-forward mechanism involving Drosophila fragile X mental retardation protein triggers a replication stress-induced DNA damage response</article-title>. <source/>Hum. Mol. Genet.
<volume>23</volume>, <fpage>5188</fpage>–<lpage>5196</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu241</pub-id><pub-id pub-id-type="pmid">24833720</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. Q.</given-names></name><name><surname>Bailey</surname><given-names>A. M.</given-names></name><name><surname>Matthies</surname><given-names>H. J.</given-names></name><name><surname>Renden</surname><given-names>R. B.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Speese</surname><given-names>S. D.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function</article-title>. <source/>Cell
<volume>107</volume>, <fpage>591</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00589-X</pub-id><pub-id pub-id-type="pmid">11733059</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. Q.</given-names></name><name><surname>Matthies</surname><given-names>H. J. G.</given-names></name><name><surname>Mancuso</surname><given-names>J.</given-names></name><name><surname>Andrews</surname><given-names>H. K.</given-names></name><name><surname>Woodruff</surname><given-names>E.</given-names></name><name><surname>Friedman</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis</article-title>. <source/>Dev. Biol.
<volume>270</volume>, <fpage>290</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2004.02.010</pub-id><pub-id pub-id-type="pmid">15183715</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>